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CHAPTER  1.  INTRODUCTION  
Protein structures are the main topic for all my research projects. Structures are important 
for proteins because they are closely related to their functions. Protein structures provide us 
clues about how the proteins work with their substrates, and where the reaction happens. 
Initially, I started with protein structure projects related to fatty acid and polyketide syn-
thesis. Three enzyme groups, acyl-CoA carboxylases, ketoacyl synthases, and thioesterases, 
were classified into families and clans according to similarities in amino acid sequences 
(primary structures) and three-dimensional structures (tertiary structures). Active sites and 
mechanisms of enzymes were also compared. Members of each family have very similar 
primary and tertiary structures and the same reaction mechanisms and active sites, suggesting 
that they have common protein ancestors. Clan members share similar tertiary structures, 
although they have different primary structures, which indicates that they are from distant 
common ancestors. Phylogenetic analysis was performed on these enzymes as well, to reveal 
the subtle diversity of sequences and producing organisms within families. 
Besides the structural classification, I also participated in constructing the Thioester-
active enzYme (ThYme) database. These three enzyme groups, together with other five 
enzyme groups and one molecule in the fatty acid/polyketide synthetic system, can be found 
in the ThYme database. 
The classification of carbohydrate binding modules (CBMs) is a recent research project. 
Using similar methods, CBMs are grouped into tribes according to the secondary and tertiary 
structures. All the work above is summarized in Chapter 2. 
Chapter 3 introduces the existing ways to classify carboxyl ester hydrolases (CEHs). EC 
numbers, substrate specificities, and primary and tertiary structural classification of CEHs are 
summarized in this chapter. Several databases, especially CAZY, ESTHER, LED, and 
MELDB, cover various parts of CEH classification. 
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The structural classification of CEHs is covered in Chapter 4 in more detail. This project 
is related to my previous study of amino acid sequences and crystal structure similarities. As 
CEHs constitute a widely used enzyme group in industry, their systematic classification in 
this project will help further understanding of their enzyme mechanisms, active sites, and 
other valuable properties. 
After doing computational work on protein structures, I became interested in the experi-
mental side of protein tertiary structures. It is well known that experimentally obtaining 
protein tertiary structures can be a challenging process. Thus, it occurred to me that I could 
use computational methods and available protein structures to observe the trends and infer 
some conclusions by mining structural data, in order to bridge the computational and experi-
mental data in various ways. Aspects like helping wet laboratory researchers to eliminate any 
redundant combination of crystallization conditions, or improving computational simulation 
results of protein structures, was to be my goal. This work, using crystallization condition 
data from the Protein Data Bank, appears in the Appendix of this dissertation. However, after 
conducting extensive work in this area, it appeared unlikely to lead to significant results. 
Some of the work dealing with fatty acid and polyketide synthases and the ThYme data-
base was conducted with my fellow graduate student David Cantu, the computer specialist 
Matthew Lemons, and the undergraduates Erin Kelly, Ryan Masluk, Christopher Nelson, and 
Armando Elizondo-Noriega. The work on CBMs was in collaboration with visiting scholar 
Caio Carvalho from Brazil, along with the undergraduate student Ngoc Phan. All the projects 
in this dissertation were advised and mentored by Dr. Reilly, who gave me helpful sugges-
tions, discussion, and valuable advice over the years. 
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CHAPTER  2.  EARLIER  RESEARCH  
Five projects will be summarized in this chapter. They include four projects conducted 
during my work toward my M.S. degree and one recent project about carbohydrate binding 
modules (CBMs). The four previous projects related to the fatty acid synthesis system 
include the construction of the ThYme database and structural classification of thioesterases 
(TEs), ketoacyl synthases (KSs), and acyl-CoA carboxylases (ACCs), according to their 
primary and tertiary structure similarity. The recent project classified CBMs into tribes by 
their available three-dimensional structures. I was second author of papers on the TEs (Cantu 
et al., 2010) and the ThYme database (Cantu et al., 2011), first author on the KS (Chen et al., 
2011) and ACC (Chen et al., 2012) papers, and third author of the CBM paper (Carvalho et 
al., 2015).  
ThYme  database  
The ThYme database was created to obtain insights into the fatty acid synthesis-related 
enzymes (Cantu et al., 2011). Each enzyme group, including acetyl-CoA synthases (ACSs), 
ACCs, acetyl transferases (ATs), KSs, ketoacyl reductases (KRs), enoyl reductases (ERs), 
hydroxyacyl dehydratases (HDs), and TEs, was classified into families. Primary structures 
within each family are similar to each other, as are their tertiary structures. The enzyme 
active sites and catalytic mechanisms are also conserved in each family, indicating these 
enzymes come from the same ancestor. Different families can be grouped into single clans, 
where their primary structures are not related, but their tertiary structures and active sites 
remain the same. Families in the same clan come from a more distant ancestor. 
Protocols and automation scripts to identify families and clans were developed. We gath-
ered query sequences for each enzyme group that are labeled as “evidence at protein level” 
from the UniProt database (The UniProt Consortium, 2009). Then we used our in-house 
scripts to run the BLAST program (Altschul et al., 1997) continuously using an E-value 
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threshold of 0.001, to classify query sequences into potential families (Cantarel et al., 2009). 
The lower the E-value in BLAST, the more similar sequences are to each other. The family 
classification was verified by multiple sequence alignment in MUSCLE (Edgar, 2004) and 
tertiary structure superposition in MultiProt (Shatsky et al., 2004) and PyMOL (DeLano, 
2002). 
Thioesterases  
According to the protocols that we developed, TEs fall into 25 families, with 12 of them 
being found in four clans (Cantu et al., 2010). Families TE1 to TE13 consist of acyl-CoA 
hydrolases. TE14 to TE19 members are acyl-ACP hydrolases. TE20 enzymes are protein-
palmitoyl hydrolases, TE21 members are protein-acyl hydrolases, and TE22 and TE23 
enzymes are glutathione hydrolases. TE24 and TE25 members are nearly all uncharacterized. 
HotDog and α/β-hydrolase folds are two most common folds among TE family 
structures. TE4 to TE15 members, as well as TE24 and TE25 enzymes, have HotDog folds, 
whereas TE2 and TE16 to TE22 enzyme structures have α/β-hydrolase folds. Other protein 
folds also exist, including NagB folds for TE1 proteins, flavodoxin-like folds for TE3 
structures, and lactamase folds for TE23 members. Most TE families have two or more PDB 
structures, except for families TE5, TE7, TE12, TE15, and TE19, where their root mean 
square deviations (RMSDs) of the distances between α-carbon atoms of different tertiary 
structures, and Pavg values, indicating the average percentages of α-carbon atoms that could 
be compared (Cantu et al., 2010), were calculated. All these families have average RMSD 
values lower than 1.8 Å and Pavg values greater than 75%, with two exceptions. 
Clans group two or more families together when they share similar tertiary structures, 
active sites, and reaction mechanisms. Tertiary structures were superimposed, and RMSDs 
and Pavg values were recorded. 
Clan TE-A includes families TE5, TE9, TE10, and TE12, where they all share a similar 
HotDog fold. Clan TE-B consists of families TE8, TE11, and TE13, with HotDog folds as 
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well. However, TE-A and TE-B share only limited sequence similarities and limited second-
ary structure elements, which make them two separate clans. α/β-Hydrolase clans TE-C and 
TE-D consist of families TE16 to TE18 and families TE20 and TE21, respectively, according 
to secondary and tertiary structure analysis. 
 The catalytic residues and mechanisms for TE families are summarized as well, if avail-
able. Various active sites and mechanisms exist in HotDog fold structures. In clan TE-A, 
Tyr7, Asp11, and His18 were proposed as the catalytic residues in PDB structure 2PZH of 
TE9. In clan TE-B, TE8 member 3F5O has Asn50, Asp65, Ser83, and Gly57 important for 
catalysis. TE11 residues Gly65 and Glu73 in 1Q4S were suggested as the catalytic residues. 
The catalytic residues in TE13 member 1WLU appear to be Gly40 and Asp48. Unlike the 
HotDog fold enzymes, which have various catalytic residues and mechanisms, α/β-hydrolase 
fold enzymes have conserved Ser-His-Asp catalytic triads. 
Ketoacyl  synthases  
Ketoacyl synthases were classified into five families, KS1 to KS5 (Chen et al., 2011). 
KS1 members are mainly 3-ketoacyl-ACP synthase III (KAS III) enzymes, which condense 
malonyl-ACP with acyl-CoA to produce acetoacyl-ACP. KS2 members are 3-ketoacyl-CoA 
synthases, fatty acid elongases, and very long-chain fatty acid (VLCFA) condensing 
enzymes, which come from eukaryota, especially plants. KS3 enzymes are generally 3-
ketoacyl-ACP synthases I and II (KAS I and KAS II), and KS domains of large multi-
functional type I fatty acid synthases (FASs). KS3 is the largest KS family, containing over 
13,000 sequences at the time of publication. KS4 members are mainly chalcone synthases, 
narigenin-chalcone synthases, stilbene synthases, and polyketide synthases. Most KS4 
sequences come from eukaryota, and the rest come from bacteria. KS5 comprises elongation 
of VLCFA proteins and fatty acid elongases. They all come from eukaryota and most of them 
are from animals. KS2 and KS5 enzymes are transmembrane proteins, producing VLCFAs. 
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KS1, KS3, and KS4 families are part of the same clan. They share the same five-layer α-
β-α-β-α protein structures. Furthermore, catalytic residues from these three families are found 
in the same positions. KS1 and KS4 sequences have the same catalytic triad, Cys-His-Asn, 
where KS3 enzymes have Cys-His-His as the catalytic residues. These three families share 
the same ping-pong kinetic mechanism (Plowman et al., 1972), using Cys-His-Asn/His 
residues. KS2 and KS5 members have no available crystal structures. Since they are 
transmembrane proteins, it is hard to obtain their crystal structures experimentally. However, 
computational simulation studies have been done on KS2 (Joubès et al., 2008) and KS5 
enzymes (Chumningan et al., 2010), respectively, where homology modeling and ab initio 
methods were applied to predict their tertiary structures. 
Phylogenetic analysis has been conducted for all five KS families to see the sequence 
diversity within each family (Chen et al., 2011). Phylogenetic trees were produced by MEGA 
(Tamura et al., 2007, 2011), with the minimum evolution method (Nei and Kumar, 2000), 
250 to 500 bootstrap iterations, and Jones-Taylor-Thronton (JTT) model values (Jones et al., 
1992). Potential subfamilies were selected based on the visual divergence, and they were 
verified by the statistical Z-value test (Mertz et al., 2005). KS1 to KS5 have 12, 10, 14, 10, 
and 11 subfamilies, respectively. KS1 phylogenetic analysis enabled an experimentalist to 
rationally select 30 representative genes of interest to characterize (S. Garg, personal com-
munication, 2013). 
Acyl-­CoA  carboxylases  
Acyl-CoA carboxylases (ACCs) consist of three functional domains: biotin carboxylases 
(BCs), biotin carboxyl carrier proteins (BCCPs), and carboxyl transferases (CTs). BCCP is a 
structural domain that swings between BC and CT domains. The BC domain adds bicarbon-
ate to the BCCP biotin moiety. Then BCCP swings to the CT domain, leaving its carboxyl 
group to acetyl-CoA, in order to form malonyl-CoA (Knowles, 1989). 
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One gene or several individual genes may encode BC, BCCP, and CT domains, which 
leads them to be in the same protein chain or in several different chains. Each domain was 
extracted from the whole sequences and classified into families according to their primary 
and tertiary structure similarities (Chen et al., 2012). There is one BCCP family (BCCP1), 
one BC family (BC1), and two CT families (CT1 and CT2). The CT1 family corresponds to 
CTβ sequences and the CT2 family contains mainly CTα sequences. 
ACCs include acetyl-CoA carboxylases, propionyl-CoA carboxylases (PCCs), methyl-
crotonoyl-CoA carboxylases (MCCs), geranoyl-CoA carboxylases (GCCs), acetone carbox-
ylases, and 2-oxoglutarate carboxylases (Chen et al., 2012). The domain arrangements for 
them were studied. Acetyl-CoA carboxylases from bacteria and plants excluding grasses 
have individual chains for BC, BCCP, CTα, and CTβ domains (Chen et al., 2012). Acetyl-
CoA carboxylases from eukaryota less plants other than grasses have all four domains in one 
multi-functional protein chain (Nikolau et al., 2003; Zhang et al., 2003; Sasaki & Nagano, 
2004). PCCs, MCC, and GCCs sequences from bacteria and eukaryota have two chains: BC 
and BCCP domains are in one chain, and the CTβ domain is in another (Toh et al., 1993; 
Rodríguez & Gramajo, 1999; Nikolau et al., 2003; Lombard & Moreira, 2011). Acetyl-CoA 
carboxylases and PCCs from archaea have three separate chains, containing BC, BCCP, and 
CTβ domains, respectively (Chen et al., 2012). 
Phylogenetic analysis was performed on each ACC family, including BC, BCCP, CTα, 
and CTβ domains (Chen et al., 2012). We used MUSCLE (Edgar, 2004) to conduct multiple 
sequence alignment (MSA) for representative sequences and MEGA (Kumar et al., 2008) to 
produce the phylogenetic trees. Potential subfamilies were selected by visual inspection and 
verified by the statistical Z-value test (Mertz et al., 2005). 
The swinging arm mechanism for BCCP to swing between BC and CT domains was first 
proposed by Waldrop et al. (1994). The facts that crystal structures of BC and CT domains in 
PCCs and MCCs are separated by 55 Å and 80 Å (Huang et al., 2010, 2011), respectively, 
supports this swinging arm theory. Bacterial acetyl-CoA carboxylases with CTα and CTβ 
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domains on separate chains have their active sites on the interface of the αβ dimers (Bilder et 
al., 2006). PCCs and MCCs from bacteria and eukaryota have two chains: BC and BCCP are  
on one chain (α subunit), CTβ is on the other (β subunit) (Chen et al., 2012). They form an 
α6β6 architecture, where their active sites are located on the dimer interface of two β subunits. 
Carbohydrate  binding  modules  
Carbohydrate binding modules (CBMs) are protein domains that associate their corres-
ponding catalytic domains with substrates, in order to increase the catalytic efficiencies of the 
active sites of the latter. CBMs fall into 67 families according to their amino acid sequence 
similarity on the Carbohydrate-Active enzyme (CAZy) database (Lombard et al., 2013). Seq-
uences within each family are statistically similar, while sequences from different families 
are not. Fifty-one of the families have at least one known tertiary structure, which enabled 
them to be further classified into tribes (Carvalho et al., 2015). Although primary structures 
from different families are not similar, similar tertiary structures can sometimes be observed, 
indicating that they are from the same distant common protein ancestor. Since CBMs have no 
catalytic function, we use the term “tribe”, to indicate their tertiary structure similarity and 
their share of same common ancestors and binding mechanisms, instead of “clan” as prev-
iously seen in TEs, KSs, and ACCs. 
In general, the same methods were applied to the classification of CBM tribes as the ones 
used with TEs, KSs, and ACCs. One representative tertiary structure from each CBM family 
was selected and overlapped with representative structures from other families. RMSDs and 
Pavg values were calculated to show their structural similarity. Secondary structure elements 
(SSEs) of CBMs were checked as well. Additional criteria for CBM structural classification 
are the configuration of ligand glycosidic bonds that CBMs bind and the CBM chain length. 
The criteria for tribe classifications in the order of importance are: SSE order and location, 
RMSDs and Pavg values, binding ligands, chain length, and their producing organisms. 
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CBM families were classified into nine tribes, CBM-A to CBM-I, containing 27 out of 51 
families, when the criteria described above were applied. Each tribe contains two or more 
families. Members of eight tribes, CBM-A to CBM-H, have β-sandwich protein folds, which 
are characterized by two antiparallel β-sheets (Sillitoe et al., 2012), although each tribe has 
its own characteristic β-strand arrangement. Members of the last tribe, CBM-I, have β-trefoil 
protein folds with threefold axes (Murzin et al., 1992), where β-strands are folded into three 
similar parts with α-helices at the corners (Carvalho et al., 2015). Members of CBM-A to 
CBM-C bind α-linked ligands only, such as starch, cyclodextrins, and glycogen, whereas 
members of CBM-D to CBM-I bind to β-linked polysaccharides, including various β-(1,4)- 
and β-(1,3)-linked glucans, galactan, mannan, and xylans, and sometimes α-linked ligands as 
well. Moreover, CBMs in one tribe often associate with more than one glycoside hydrolase 
(GH) family (Carvalho et al., 2015). 
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CHAPTER  3.  ENZYME  DATABASES  
Carboxylic  ester  hydrolases  
The carboxylic ester hydrolases (CEHs) catalyze the hydrolysis of a carboxylic ester 
bond to generate a carboxylate and an alcohol (Fig. 1). Because of their importance in 
pharmaceutical, food, and detergent industries, they are among the most studied enzymes in 
industry. The active sites of CEHs are Ser/His/Asp catalytic triads, together with oxyanion 
holes near the catalytic sites. 
Figure 1. Reactions catalyzed by CEH enzymes. 
The widely studied CEHs include carboxylesterases (EC 3.1.1.1) for their important role 
in the metabolism of a large number of diverse drugs (Satoh and Hosokawa, 1998); triacyl-
glycerol lipases (EC 3.1.1.3) for their triacylglycerol synthesis and secretion for energy stor-
age and release of fatty acids (Lehner and Kuksis, 1996); phospholipase A2’s (EC 3.1.1.4) 
for their production of free fatty acids such as arachidonic acid and the lysoglycerophospho-
lipids, which are the precursors of eicosanoids that play a role in sleep regulation, inflammat-
ion, and immune responses (Schaloske and Dennis, 2006); lysophospholipases (EC 3.1.1.5) 
for their kinetic resolution of racemic mixtures of industrial chemicals (Lo et al., 2003); 
acetylcholinesterases (EC 3.1.1.7), as they are the targets of nerve agents, insecticides, and 
therapeutic drugs, in particular the anti-Alzheimer drugs (Silman and Sussman, 2005); 
butyrylcholinesterases (EC 3.1.1.8) for their involvement in drug hydrolysis to explain drug 
responses in individuals with diseases (Li et al., 2005); phospholipase A1’s (EC 3.1.1.32) for 
their inhibition of cationic amphiphilic drugs like chlorpromazine, chloroquine, and propran-
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olol (Kubo and Hostetler, 1985); cutinases (EC 3.1.1.74) for their hydrolysis of cutin to 
produce C16 and C18 fatty acids (Nicolas et al., 1996; Egmond, 2000); and cocaine esterases 
(EC 3.1.1.84) for their natural role in cocaine metabolism (Larsen et al., 2001; Gao et al. 
2009). 
Enzyme  classification  
Enzymes can be classified into groups by different criteria. One widely used method is to 
classify them based on the chemical reactions that they catalyze, according to the Enzyme 
Commission (NC-IUBMB, 1992). This way of enzyme classification is presented by a four-
digit nomenclature. The four-digit EC number describes enzyme functions in more and more 
detail. The first digit ranges from one to six, representing oxidoreductases, transferases, 
hydrolases, lyases, isomerases, and ligases, respectively. Enzymes of EC 3 are all hydrolases, 
and EC 3.1 enzymes are a subgroup of hydrolases that act specifically on ester bonds. EC 
3.1.1 represents enzymes hydrolyzing a carboxylic ester bond, to form an alcohol and a 
carboxylate. An enzyme will be assigned an EC number once its function is known. Taking 
CEHs as an example: They are assigned EC numbers 3.1.1.X, where X can be any digit 
between 1 and 97. 
Substrate specificities are another way to classify enzymes. CEHs are commonly classi-
fied into two groups: esterases and lipases. Esterases catalyze the water-soluble short-chain 
fatty acids, while lipases prefer the long acyl chain, water-insoluble fatty acids as substrates. 
Enzymes can be classified by their primary structures (amino acid sequences) and tertiary 
structures (three-dimensional structures) as well. The Pfam database (Sonnhammer et al., 
1997; Bateman et al., 2004) classifies proteins into domains and families according to their 
primary structures by multiple sequence alignment. It uses Hidden Markov Model profiles to 
find the domains in new sequences. Pfam covers about 80% UniProt knowledgebase proteins 
(Punta et al., 2012). The CATH (Sillitoe et al., 2012) and SCOP databases (Murzin et al., 
1995) classify enzymes mainly by their tertiary structures. CATH assigns four hierarchies to 
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each protein: class, architecture, topology, and homologous superfamilies. The class indicate 
the secondary structure composition of the proteins: mainly α-helices, mainly β-strands, α 
and β structures, or a few irregular secondary structures. Then, proteins are classified into 
more detailed groups within their class, represented by a four-digit CATH number. 
CAZy (Lombard et al., 2013) and ThYme (Cantu et al., 2011) are databases that special-
ize in particular protein groups. The CAZy database is built for carbohydrate-active enzymes, 
and the ThYme database is for thioester-active enzymes. They classify enzymes into families 
and clans by their similarities in both primary structures and tertiary structures. They are 
comprehensive databases that integrate enzyme information about sequences and their 
producing organisms, active sites, mechanisms, and tertiary structures. They contain links to 
external databases such as GenBank and the Protein Data Bank. Within each family, amino 
acid sequences, tertiary structures, and reaction mechanisms are conserved. Within each clan, 
tertiary structures and mechanisms are well conserved, although their primary structures are 
completely different from each families in the same clan. 
Enzyme  databases  for  CEHs  
ESTHER is a database of α/β-hydrolase-fold proteins and their classification (Hotelier et 
al., 2004), tabulating the sequences, three-dimensional structures, and biochemical and 
pharmacological information about these proteins. Typical α/β-hydrolase folds are a β-sheet 
connected by several α-helices. Usually, there are five to eight β-strands on the β-sheet, with 
the second β-strand antiparallel to the other β-strands (Ollis et al., 1992; Hotelier et al., 2004; 
Lenfant et al., 2013).	  The number of families has expanded from 69 in 2004 to 148 in 2013, 
with over 30,000 manually curated proteins (Lenfant et al., 2013). The ESTHER database 
takes in all α/β-hydrolase-fold proteins, including proteins other than CEHs such as the 
peptidases and thioesterases, as long as they have the α/β-hydrolase fold. Some non-catalytic 
proteins with the same fold are also included. CEHs are a substantial group of enzymes in the  
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ESTHER database; however, they exist in other protein folds as well, such as six-propeller 
folds and three-solenoid folds. 
The CAZy database (Lombard et al., 2013) contains a group of carbohydrate esterases 
(CEs) that belong to the CEHs. Since CAZy includes carbohydrases exclusively, only 
enzymes acting on carbohydrates are found in it. 
The Lipase Engineering Database (LED) integrated sequence and tertiary structure infor-
mation of esterases, lipases, and other related proteins with α/β-hydrolase folds (Fischer and 
Pleiss, 2003; Fischer et al., 2006; Widmann et al., 2010). The enzymes in LED covered eight 
EC numbers under 3.1.1.X, with 38 LED superfamilies being assigned to about 25,000 
sequences and over 1000 tertiary structures. The cutoff was a BLAST E-value of 10–10 in 
LED, which is lower than those being used in the CAZy and ESTHER databases. This led to 
a smaller family size and a higher sequence similarity in family members than found in 
ESTHER families. Annotated multiple sequence alignments for catalytic residues, binding 
sites and mutation, and phylogenetic trees of each family were available on the database. 
LED has not been updated since 2010. 
MELDB is a database that covers microbial carboxylesterases and triacylglycerol lipases, 
which are enzymes in EC 3.1.1.1 and EC 3.1.1.3. These two enzyme groups are classified by 
the primary and tertiary structure similarities. It aimed to find new biocatalysts with unique 
biochemical properties, and to study directed evolution (Kang et al., 2006). The researchers 
applied a local alignment algorithm and TribeMCL (a graph clustering algorithm), instead of 
the common global pairwise alignment. These methods reduced the noise introduced by the 
global alignment, and they were able to distinguish the outlier sequences successfully, 
whereas the traditional methods were not. The MELDB classification mainly corresponds to 
part of the LED database. The MELDB database has not been updated since 2006. 
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CHAPTER  4.  STRUCTURAL  CLASSIFICATION  OF  
CARBOXYLIC  ESTER  HYDROLASES  
Abstract  
The carboxylic ester hydrolases (CEHs) are enzymes that hydrolyze an ester bond to 
form a carboxylic acid and an alcohol. They are one of the enzyme groups that are most 
explored industrially for their applications in the food, flavor, pharmaceutical, organic 
synthesis, and detergent industries. 
We classified CEHs into families and clans according to their amino acid sequences 
(primary structures) and three-dimensional structures (tertiary structures). Our work has 
established the systematic structural classification of the CEHs. Primary structures of family 
members are similar to each other, and their active sites and reaction mechanisms are 
conserved. The tertiary structures of members of each clan, which is composed of different 
families, remain very similar, although amino acid sequences of members of different 
families are not similar. 
CEHs were divided into 127 families by use of BLAST, with 67 families being grouped 
into seven clans. Multiple sequence alignment and tertiary structures superposition were 
used, and active sites and reaction mechanisms were analyzed. Python and Shell scripts were 
implemented to automate the process of comparing CEH primary and tertiary structures. 
A comprehensive database, CASTLE (CArboxylic eSTer hydroLasEs), may be 
constructed to provide the primary and tertiary structures of CEHs. This database would be 
available at www.castle.enzyme.iastate.edu and will be accessible to the entire biology 
community. 
Introduction  
There are two common kinds of carboxylic ester hydrolases (CEHs): esterases and 
lipases. Esterases hydrolyze water-soluble acyl chains of fatty acids, and lipases hydrolyze 
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water-insoluble long-chain fatty acids, in each case cleaving an ester bond to form a 
carboxylic acid and an alcohol. CEHs are one of the enzyme groups that most explored 
industrially, because of their wide use in the food, flavor, pharmaceutical, organic synthesis, 
and detergent industries (Hasan et al., 2006). 
CEHs are ubiquitous in all life forms: viruses, archaea, bacteria, and eukaryota. Esterases 
and lipases are two important classes of CEHs. The esterases prefer shorter acyl esters, fewer 
than ten carbon atoms, than the lipases (Levisson et al., 2009). According to the CATH 
numbers assigned to CEH tertiary structures (Sillitoe et al., 2013), many of them have α/β-
hydrolase folds, which are composed of three α/β/α layers, with the second β-strand being 
antiparallel to the others in the β-sheet (Ollis et al., 1992; Andreeva et al., 2007). Others may 
be composed of only α-helices or only β-strands. Some CEH structures have six-propeller 
folds, which consist of a six-bladed β-sheet with a central axis. Some have four-layer sand-
wich folds, where several anti-parallel β-strands are arranged in two β-sheets. Three-solenoid 
folds are also found in CEH structures; they consist of many parallel β-strands arranged into 
three β-sheets. The outer-membrane CEHs are commonly found in β-barrel folds. 
To this point there is no systematic structural classification of CEHs. The CAZy database 
(Lombard et al., 2013) has classified some of these enzymes, but only the carbohydrate ester-
ases, which catalyze the de-O- or de-N-acylation of substituted saccharides. Other CEHs 
such as triacylglycerol lipases and acetylcholine esterases are not included in this classificat-
ion. The ESTHER database (Hotelier et al., 2004; Lenfant et al., 2012) covers part of the 
CEHs, focusing on the classification of α/β-hydrolase fold structures. It is not limited to 
CEHs, but includes other enzymes such as peptidases and thioesterases that have this fold. 
The LED database (Fischer and Pleiss, 2003) classified lipases and esterases by their func-
tion, sequences, and crystal structures. The database covered nine EC numbers under EC 
3.1.1.X, where X represents digits between 1 and 97. Its founders employed much smaller E-
values in their use of BLAST, the Basic Local Alignment Search Tool (Altschul et al., 1997)  
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to gather primary structures than do the curators of CAZy, implying that the family members 
in LED were more similar to each other. However, it has not been maintained since 2009. 
The research reported in this chapter systematically classifies the CEHs by their primary 
and tertiary structure similarities. This will cast light on the various ways that CEHs with 
different primary or tertiary structures catalyze the same reaction. A comprehensive database, 
CASTLE (CArboxylic eSTer hydroLasEs), will be constructed, to make CEH structural 
information and their classification fully accessible to the research community over the 
world. The database will be available at www.castle.enzyme.iastate.edu. 
Methods  
Potential  CEH  family  identification  
To classify the CEH proteins, the query sequences of CEH needed to be gathered first. 
The EC number (NC-IUBMB, 1992) indicates the enzyme function, with CEHs being found 
under EC 3.1.1.X, where X represents any number at the fourth position to describe the CEH 
function in greater detail. As the time of writing, CEHs were classified by 91 EC numbers, 
from EC 3.1.1.1 to EC 3.1.1.98 and EC 3.1.1.– (unclassified), with seven of them being 
deleted. All the sequences with evidence at protein level in the UniProt database (UniProt 
Consortium, 2008) of these EC numbers were collected as query sequences. The criterion of 
evidence at protein level is to ensure that wet laboratory experiments have been done on 
these proteins to verify their protein functions as CEHs. This criterion ruled out a large 
portion of protein sequences in EC 3.1.1.X obtained from whole-genome projects, whose 
functions are putative because their sequences have only been compared with those with 
known CEHs, but whose functions have not been verified experimentally.  
Query sequences were checked on the Pfam database (Finn et al., 2010) to obtain their 
catalytic domains only. BLAST was used consecutively to find similar primary structures of 
these catalytic domains. The up-to-date NR database, which gathers non-redundant protein 
sequences from various databases such as PDB, PIR, Swiss-Prot, and NCBI RefSeq, was 
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used to search similar sequences against the query sequences. The threshold E-value in 
BLAST was set to 0.001. Protein sequences with an E-value lower than 0.001 were regarded 
as similar enough to the query sequence to be included in one potential family (Cantu et al., 
2010). In-house Python and Shell scripts were implemented to automate the process of 
obtaining catalytic domains of query sequences in Pfam, and performing BLAST consec-
utively to find potential families. All the scripts were run on the Google cloud platform with 
Linux Cent OS7 installed. 
After each run of BLAST using query sequences, one result file for each resulting outseq 
file was generated, and sequences within the result file comprise a potential family. The 
potential families needed to be verified by multiple methods, which will be discussed in the 
next section. 
CEH  family  verification  
Multiple sequence alignment (MSA) and tertiary structure superposition are two main 
techniques to verify the potential families, with the possibility of merging or splitting them. 
A sample of random sequences in each potential family was used to perform the MSA. 
The alignment is to ensure that these sequences are similar enough, with several positions of 
amino acid residues conserved along the entire sample. If no amino acid residue is conserved 
and if clear differences are observed in the MSA result, then the potential family was split 
into multiple families. 
The tertiary structures from each potential family, if available, were superimposed. The 
monomer of each tertiary structure was extracted and compared. The root mean square 
deviation (RMSD) of the α-carbon atoms was calculated, together with the Pavg, indicating 
the percentage of atoms that can be compared (Cantu et al., 2010; Chen et al., 2011). 
Furthermore, the active sites of the enzyme should remain in the similar position within 
each family. If active sites were already known in the literature, their positions were checked.  
  
	   25	  	  
Also, secondary structure elements were compared and analyzed to ensure that each family 
has almost the same elements. 
CEH  clan  identification  
Clans are composed of two or more different families, where their active sites, reaction 
mechanisms, and tertiary structures are conserved from family to family, although their 
primary structures are not similar from one family to the next. We used folds defined by 
CATH (Ollis et al., 2015) to first divide the tertiary structures into separate groups. Tertiary 
structure representatives from different families were superimposed by MultiProt (Shatsky et 
al., 2004). RMSD and Pavg values were calculated to determine whether they are similar 
enough to be in a clan. Varying from previous methods to calculate RMSD and Pavg, pairwise 
RMSD and Pavg values were calculated for representative structures from each family. This 
variation is caused by the large number of families with the same fold, which is difficult to 
visually distinguish in PyMOL (DeLano, 2002) to find potential clans. 
Each combination of two representative structures from different families were superim-
posed by MultiProt, and their pairwise RMSD and Pavg values were recorded in matrices, to 
cluster different families with the same folds assigned by CATH into potential clans. The 
superposition in MultiProt, along with RMSD and Pavg calculations, were implemented by 
Python scripts. To cluster similar structures into potential clans, the pairwise RMSD matrix 
were imported into MEGA 6.06 (Tamura et al., 2013), and neighbor joining trees were 
produced in the form of curved and circular trees. Although MEGA was intended to produce 
phylogenetic trees for the study of molecular evolution, the pairwise distance matrix used in 
MEGA is similar enough to be used for the RMSD matrix. Thus, we used MEGA to analyze 
the RMSD matrix produced by the pairwise structure superposition, in order to cluster the 
CEH tertiary structures. Potential clans were proposed according to the trees. Then the struc-
tures of potential clan members were superimposed and inspected in PyMOL. The proposed 
classification was tuned until the structures superimposed in PyMOL were in good align-
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ment. Interestingly, the pairwise alignments did not perform as well as visual inspection. 
With visual inspection, similar PDB structures from different families were grouped roughly 
into potential clans, then their PDBs were superimposed by MultiProt. 
CEH  clan  verification  
RMSD and Pavg values were calculated for structures within each potential clan, after the 
structure superposition by MultiProt, and the structures were visually inspected in PyMOL. 
This is to ensure that the tertiary structures are more similar to others in one clan than to 
those from other clans. Active sites were checked, if available, to see whether the catalytic 
residues are in similar positions to act on the substrates, and share the same mechanism in 
each clan. 
Results  
The potential 130 families became 127 families after MSA using ClustalW and structure 
superposition by MultiProt and PyMOL. Among them, 91 families have known PDB struc-
tures, and 68 of them were grouped into seven clans. In addition, 36 families have no avail-
able tertiary structures (Table 1). 
Each clan has its characteristic protein folds. Clan A proteins all have α/β hydrolase 
folds, in which the second β-strand is antiparallel to the others in the β-sheet (Ollis et al., 
1992) (Figure 1). Clan B members have similar folds as those in clan A; however, all their β-
strands are parallel to each other and are in the same direction. Clan C enzymes have α/β 
hydrolase-like tertiary structures as well, but their first β-strands are antiparallel to the others 
on the same β-sheet, whereas Clan A’s second β-strands are antiparallel. The tertiary struc-
tures of clan D members are six-propeller folds, where six β-sheet blades share a central axis. 
Clan E enzymes have three-helix folds, and clan F proteins share three-solenoid folds, which 
consist of many parallel β-strands gathered into three β-sheets, comprising the solenoid-
shape protein fold. Clan G members have 4-layer α/β/β/α sandwich folds. Furthermore, folds 
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with β-barrels exist in outer-membrane CEHs, and 3-layer sandwich folds exist in CEHs as 
well. Families with these structures cannot be grouped into clans, because their members 
have various shapes and cannot be superimposed well, although they share the same fold. 
Each family was verified by three methods: MSA, secondary structure analysis, and 
tertiary structure superpositions. The sequence alignment files from Clustal X can be found at 
the dissertation supplemental materials at the following URL: 
(https://www.dropbox.com/sh/x4jhjbv5fgs9jzl/AADRadnpC-EPhQHALfr2mWvOa?dl=0). 
The conserved amino acid counts for each family are summarized in Table 2, as are RMSD 
and Pavg values obtained by tertiary structure superposition. Clan members of various fami-
lies can be found in Table 3, where RMSD and Pavg values of each clan member are listed, 
and the protein folds of each clan are summarized. Representative tertiary structures from 
seven clans are shown in Figure 1. The secondary structures of crystal structures in each 
family are obtained by secondary structure analysis (Supplementary Information Figure S1). 
Each clan member has similar secondary structures in their cores, with some extra α-helices 
or β-strands. 
Family  and  clan  numbering  
The families were reordered so that all those in the same clan were numbered consecut-
ively. Then families with no PDB structures, which cannot be grouped to clans, were listed 
below these families. 
Family  content  
Phospholipase A2’s (EC 3.1.1.4 and EC 3.1.1.5) 
The phospholipase A2 (PLA2) enzymes catalyze the hydrolysis of fatty acids from the sn-
2 position of glycerophospholipids, to generate free fatty acids (Schaloske and Dennis, 2006) 
(Figure 2). They are drug targets for inflammatory disease and coronary heart disease (Burke 
and Dennis, 2008a; Corbett et al., 2010). The PLA2’s have five main types: the secreted 
sPLA2’s, cytosolic cPLA2’s, calcium-independent iPLA2’s, PAF acetyl hydrolase lpPLA2’s, 
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and lysosomal PLA2’s. The first four types are EC 3.1.1.4 phospholipases, and the last type 
are EC 3.1.1.5 lysophospholipases. sPLA2’s have histidine (His) and aspartic acid (Asp) 
residues as a catalytic dyad, with an oxyanion hole near to the active site. The cPLA2’s have 
the same catalytic residues as other CEH families and require Ca2+ in the reaction. However, 
they are regarded as an individual family, because they have a substrate preference of arach-
idonic acid in the sn-2 position of phospholipids (Clark et al., 1991; Ghosh et al., 2006; 
Burke and Dennis, 2008a). The iPLA2’s are enzymes that can catalyze reactions without the 
presence of Ca2+. They use a serine residue to cleave the sn-2 ester bond. Among them, the 
most characterized enzymes are the iPLA2’s, which are regulated through many mechanisms 
such as ATP binding, calmodulin, caspase cleavage, and possible protein aggregation caused 
by intervening ankyrin repeats (Burke and Dennis, 2008a,b). The iPLA2’s are also important 
in axon regeneration and wallerian degeneration in nerve injury (Burke and Dennis, 2008a; 
López-Vales et al., 2008). The PFA acetyl hydrolase/oxidized lipid lpPLA2’s can cleave 
oxidized lipids in the sn-2 position, from acetyl up to acyl groups with nine carbon atoms. 
They use the Ser/His/Asp catalytic triad, instead of the active dyads in all the other PLA2’s. 
These enzymes have anti-inflammatory activity in vivo, according to studies of PLA2 from 
human plasma (Tjoelker et al., 1995; Burke and Dennis, 2008a). PAF lpPLA2’s show a 
positive risk factor in coronary heart disease and are a promising drug target. Lysosomal 
PLA2’s use Ser/His/Asp as the catalytic triad, and they need four cysteine residues in total 
for catalytic activity (Hiraoka et al., 2002, 2005; Burke and Dennis., 2008b). The PLA2 
enzymes exist in families 33 and 35 in clan A, families 61–63 in clan E, and in families 68, 
72, 74, 77, 82, 85, 116, 123, and 124 that are not part of clans. Lysophospholipases are in 
families 13, 20, 33, and 35 in clan A, families 39, 48, and 51 in clan B, family 52 in clan C, 
and families 90, 104, 123, 124, 126, and 127 that are not part of clans. 
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Cholinesterases (EC 3.1.1.7 and EC 3.1.1.8)  
The cholinesterases have two groups of enzymes: acetylcholinesterases (AChE’s, EC 
3.1.1.7) and butyrylcholinesterases (BChE’s, EC 3.1.1.8) (Figure 3). AChEs hydrolyze 
acetylcholine to produce choline and acetate. Acetylcholine is a neurotransmitter that carries 
signals from nerve cells to muscle cells, and the reaction to generate acetylcholine happens 
very fast. The AChE inhibitors are drug targets for psychotropic diseases such as Alz-
heimer’s (Cummings, 2000; Houghton et al., 2006). There are substantial structural studies 
on this enzyme group because of their medical importance. Tertiary structures of cholin-
esterases have a deep (20 Å) “catalytic gorge”, and the active sites are located at the bottom 
of this gorge. The AChE from the electric eel Torpedo californica (tcAChE), has the active 
site Ser200/His440/Glu327 (Sussman et al., 1991; Ordentich et al., 1998; Zhang et al., 2002). 
Human BChE (huBChE) has a structure similar to that of tcAChE, and their catalytic triad is 
Ser198/His438/Glu325 (Vellom et al., 1993; Suárez and Field, 2005). Besides their active 
sites, AChE’s have a peripheral site at the entrance of the narrow gorge, and they are the 
binding sites for propidium (Barak et al., 1997; Johnson and Moore, 1999) and antibodies 
(Saxena et al., 1997). AChE sequences are in family 34 in clan A and families 41 and 43 in 
clan B. Hysteresis of BChEs has been observed in human, rats, and horse types. It was pro-
posed that oscillations occurred when substrates exist in different conformation, interconver-
tible, and aggregation forms. Although there is no evidence that hysteresis plays a role in 
BChE functioning, a toxicological or physiological importance for the BChE hysteresis 
cannot be ruled out (Masson et al., 2005). Kinetic studies of BChE have been conducted. The 
Km for substrates decreased as the length of alkyl chain increased, and the longest chain-
length substrates have high affinity of BChE enzymes. Molecular modelling revealed that the 
docking energy decreased as the alkyl chain length increased. The best substrates for rat 
BChEs were short alkyl homologues (Hrabovska et al., 2006). BchE enzymes are in family 
34 of clan A. 
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Carboxylesterases (EC 3.1.1.1) 
Carboxylesterases (CarbE’s) are enzymes that hydrolyze carboxylic ester bonds to pro-
duce carboxylates and alcohols (Figure 4). CarbE’s catalyze the hydrolysis of a substantial 
number of drugs as substrates, such as cocaine, salicylate, palmitoyl-coenzyme A, and 
steroids (Satoh and Hosokawa, 1998). The metabolism of heroin and cocaine is the same in 
human liver CarbE’s (Kamendulis et al., 1996). Satoh and Hosokawa (1998) classified 
mammalian CarbE’s into four groups, CES1 to CES4, where subgroups of CES1 are from 
CES1A to CES1C. Human CarbE’s are CES1A1 and CES1A2, as are other mammalian 
CarbE’s, including those from rats, mice, rabbits, and dogs. CES1B’s preferentially 
hydrolyze long-chain acyl-CoA’s. In a 2006 study by the same group, the phylogenetic trees 
expanded from CES1 to CES5, and the CES1 subgroups expanded from CES1A to CES1H. 
CarbE catalytic amino acid residues are Ser/Glu/His. A comparison of substrate specificities 
is included in the work as well: CES1’s preferentially hydrolyze cocaine, meperidin, and 
temocapril; CES2’s prefer heroin, CPT11, and methylprednisolone 21-hemisuccinate (Satoh 
and Hosokawa, 2006). Families 6, 9, 11, 15, 17, 27, and 36 in clan A, families 39, 40, 45, 47, 
and 51 in clan B, family 52 in clan C, and family 110, which is not in any clan, have CarbE 
enzymes. 
Cutinases (EC 3.1.1.74) 
Cutinases are named for their hydrolysis of ester bonds in cutin, to produce mainly C16 
and C18 fatty acids, and they can also catalyze the hydrolysis of short- and long-chain triacyl-
glycerols (TAGs) (Egmond and De Vlieg, 2000) (Figure 5). Cutinases bridge the esterases 
and lipases in terms of their substrate specificities (Martinez et al., 1993). Esterases hydro-
lyze water-soluble short acyl chains, whereas lipases hydrolyze water-insoluble long chains 
(Chahiniana and Sarda, 2009). Cutinases have the catalytic mechanism as serine esterases, 
where they use Ser120, Asp175, and His188 as their catalytic residues, with two nitrogen 
atoms of Ser42 and Gln121 as the oxyanion hole (Martinez et al., 1993, 1994; Nicolas et al., 
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1996). The catalytic residues of bacterial Thermobifida fusca cutinase are Ser170, Asp216, 
and His248, while Tyr100 and Met171 act as the oxyanion hole (Chen et al., 2008). The 
catalytic serine residue is located at the fifth β-strand on a sharp turn, or the so-called 
nucleophile elbow (Egmond and De Vlieg, 2000). Homology modeling was performed on a 
bacterial cutinase from Thermobifida fusca, using fungal Streptomyces exfoliates lipase as a 
template, because they were the best match in MSA and they share 63% sequence identity. 
Potential synergistic effects between two T. fusca cutinases were studied as well, and there 
was no synergism between them, suggesting that further studies about the reason why two 
genes for T. fusca cutinases are needed (Chen et al., 2008). Cutinases are in families 41 and 
43 in clan B. 
Phospholipase A1’s (EC 3.1.1.32) 
Phospholipase A1’s (PLA1’s) catalyze hydrolysis of the sn-1 ester bond of phospholipids 
to produce 2-acyl-lysophospholipids. Ser/Asp/His is the catalytic triad of PLA1 (Aoki et al., 
2002) (Figure 6). Phosphatidylserine-specific PLA1 (PS-PLA1) is involved in three kinds of 
reaction to convert PS and 1-acyl-2-lysoPS to 2-acyl-1-lysoPS. PS affects blood coagulation, 
marker of apoptosis, phagocytosis, and activation of intracellular enzymes. 1-Acyl-2-lysoPS 
is involved in the activation of mast cells and potentiation of NGF-induced neural cell differ-
entiation. 2-Acyl-1-lysoPS contributes in the growth suppression of T cells, along with the 
activation of mast cells. PLA2’s hydrolyze PS into 1-acyl-2-lysoPS, and PS is hydrolyzed by 
PS-PLA1 to produce 2-acyl-1-lysoPS (Aoki et al., 2002). Scandella and Kornberg (1971) 
characterized PLA1 substrate specificities for phase-induced, latent, and purified PLA1 for 1-
acyl attack. The substrates are phosphatidylethanolamine (PE), lysoPE (T4-infected cells), 
lysoPE (osmotic lysis), lysoPE in vitro, 1-acyllysoPE, with hydrolysis of 15, 15, 20, 25, and 
98%. Their saturated:unsaturated fatty acid ratios are 0.81, 0.29, 0.33, 0.35, and 2.9, respec-
tively. Cationic amphiphilic drugs like chloroquine, chlorpromazine, and propranonol inhibit 
PLA1 in vitro (Pappu and Hostetler, 1984; Hostetler et al., 1985). Chloroquine competitively 
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inhibits PLA1 by forming EI2 complexes. Chlorpromazine and propranonol bind to small 
unilamellar liposome substrates in a positive and collaborative way with two binding sites: a 
low-affinity site with high capacity, and a high-affinity low-capacity site (Kubo and Hostetler, 
1985). PLA1’s exist in family 49 in clan B, and in families 71, 72, 74, and 85 among those 
enzymes not in clans. 
Cocaine esterases (EC 3.1.1.84) 
Cocaine esterases (CocE’s) are the natural enzymes for treating cocaine overdose and 
addiction. CocE is the first enzyme in the metabolism of cocaine degradation. The first CocE 
crystal structure was reported by Larsen and colleagues (2002) (Figure 7). It has three 
domains: (a) a canonical α/β hydrolase fold; (b) an α-helical domain that is a lid above the 
active site; and (c) a jelly-roll-like β-domain that interacts with the previous two domains. 
Their study suggested the substrate recognition is between the highly evolved specificity 
enzyme pocket and the benzoyl moiety of cocaine. The catalytic triad is Ser117/His287/ 
Asp259 with Try118 and Try44 of the PDB structure 1JU3 in the oxyanion hole (Larsen et 
al., 2002). Gao and his co-workers (2009) rationally designed mutants of CocE to improve its 
thermostability. The computational simulation followed by in vitro and in vivo experimentat-
ion obtained about a 30-fold increase in plama half-life of CocE. The simulation first inden-
tified the weakest domain at a high temperature. Then, it virtually screened the possible 
mutants through interaction energy calculation, and used the most promising thermostable 
mutants to test in wet laboratory experimentation. This successful case provides a valuable 
strategy towards their dramatic implications on CocE therapeutic potentials. CocE’s are in 
family 116. 
Triacylglycerol lipases (EC 3.1.1.3) 
Triacylglycerol lipases hydrolyze triglycerols to diacylglycerols and carboxylates. Tri-
acylglycerols (triglycerides, TGs) are the main energy storage molecules and fatty acids in 
most living organisms (Yen et al., 2008) (Figure 8). Two primary sources of fatty acids for 
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triacylglycerol synthesis are diet and de novo synthesis. The tissues that most actively 
synthesize triglycerols are liver and intestine, where adipose tissue is known for the storage 
of triacylglycerols and release of fatty acids as albumin-bound complexes in plasma. In liver, 
brain and other tissues, there are two main places for acyl chain elongation, one in the 
mitochondria, and the other in the endoplasmic reticulum (Lehner and Kuksis, 1996). The 
catalytic triad was reported in the X-ray structure of Mucor miehei triglyceride lipase as 
Ser144/His257/Asp203 in PDB 1TGL (Brady et al., 1990). Family 26 in clan A, family 40 
clan B, and family 100 in no clan have triacylglycerol lipases. 
Comparison  with  existing  databases  
Several enzyme databases have classified a partial list of carboxyl ester hydrolases. The 
ESTHER database (Hotelier et al., 2004; Lenfant et al., 2013) focuses on α/β hydrolase fold-
like enzymes. ESTHER has three types of blocks, and 94 rank 1 families and 174 rank 2 
families, among which 42 rank 1 families have sequences from our CEH families. These 42 
ESTHER families contain 28,349 sequences. Each of the three blocks on ESTHER indicates 
their sequences come from the common ancestor. Block C overlaps with sequences from our 
family 34. Block L has sequences from families 49, 51, and 105. Block X has CEH sequen-
ces from families 5–7, 10, 11, 14, 16, 22, 23, 26, 45, and 54. 
Carbohydrate esterase (CE) families on CAZy contain 16 families, and seven of them 
overlap with the sequences from our CEH families (Cantarel et al., 2009; Lombard et al., 
2013). These seven families include 17,060 sequences, and they have sequences from 17 
CEH families: 19, 25, 27, 32, 37, 41, 43, 44, 46, 64, 65, 73, 81, 86, 92, 98, and 119. The 
Lipase Engineering Database (LED) has three classes, 38 superfamilies, and 112 families of 
lipases (Fischer and Pleiss, 2003; Fischer et al., 2006; Widmann, 2010). The LED database 
contains 24,783 sequences with 1117 PDB structures. CEH families are more inclusive than 
these three databases, because they contain about 480,000 sequences and 2101 PDB 
structures. 
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Discussion  
Classifying CEH enzymes into families and clans provides valuable insights about them. 
Several observations may be made about their structural classifications: 
1) Some CEHs with the same enzyme function appear in multiple families and clans. For 
instance, PLA2’s are found in 14 families and two clans, suggesting that they have two kinds 
of tertiary structures. Cholinesterase sequences are from 14 families and three clans. 
2) Each clan includes diverse enzymes with various functions. The biggest clan (clan A) 
includes enzymes with six different EC numbers and more than six enzyme functions. Clan B 
contains enzymes with five EC numbers. 
3) Some families show little experimental work on their enzymes. Fourteen families com-
posed of 11,122 sequences have only one sequence of evidence at protein level for each 
family, and in addition they have no known tertiary structure. These families have between 
13 (CEH 68) to 3091 (CEH 90) sequences. The fourteen families need more attention from 
researchers, because these unexplored enzymes may have novel substrate specificities that 
will be useful or important to industrial or medical applications. 
4) Another scenario is that the same enzymes occur in multiple families and clans, but they 
have few studies on them. These enzymes have more than one type of tertiary structures 
catalyzing the same reaction. They can be good study targets for researchers interested in the 
structure-function relationships. For instance, arylesterases (EC 3.1.1.2), acylglycerol lipases 
(EC 3.1.1.23), 3-oxoadipate enol-lactonases (EC 3.1.1.24), aminoacyl-tRNA hydrolases (EC 
3.1.1.29), and acetylxylan esterases (EC 3.1.1.72) have sequences from five different fami-
lies, respectively. However, each enzyme has no or only a few tertiary structures, and many 
families containing them have no tertiary structure of them. 
CASTLE  database  applications  
The CASTLE database, if constructed, would provide useful classified CEH-related 
enzyme information. It would be an essential tool for the scientists working on CEH enzymes. 
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It reveals the families and clans, where few studies have been done. These unexplored fami-
lies may hide some valuable CEH enzymes that are suitable for industrial or medical use.  
CASTLE would also summarize the widely explored families and clans, by listing their exist-
ing sequences and tertiary structures, reaction mechanisms, and substrate specificities. 
As with the previous success of CAZY and THYME databases, the CASTLE database 
would aim to help researchers access comprehensive information and resource about CEHs. 
More conclusions can be deduced from the CASTLE classification. For instance, it is known 
that within each family, the active sites, tertiary structures, and reaction mechanism remain 
the same. With existing information about any of the three, family members have the same 
properties as the experimentally studied enzymes. This will help to clarify a large portion of 
the sequences from the genome projects, with no experiments on them. CASTLE would also 
provide insights about the sequence, structure and function relationship, which will help 
scientists rational design CEHs for desired substrate specificities. Last but not least, the 
classification of CEH families and clans can be used as a uniformed nomenclature of existing 
CEHs, which have various names and aliases. 
Future  work  
Although substantial work has been done in this project, further studies can be done in 
several aspects. For the CASTLE database, more interactive ways to obtain the targeted 
enzyme data can be developed, compared to the PDB database as a successful case. The 
sequences and tertiary structures to download can be written into various formats, including 
csv and Excel spreadsheets. Diverse ways to access the data can be created, such as SQL or 
drop-down lists. The Python and Shell scripts created for this project will be uploaded to 
Github, an open source community, for maintenance and improvement purpose. This may 
include further improvement of existing scripts for better performance and usability, and 
construction of a new database similar as CASTLE. It also provides an online space for 
putting together all the scripts and tracking updates for the scripts.  
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Table 1. Clans and families of carboxyl ester hydrolases. 
 ________________________________________________________________________________________________ 
Family Number of Number of Number of Dominant, secondary, tertiary enzyme names  EC 
 sequences sequences with known  numbers 
 evidence at tertiary 
 protein level structures 
 ________________________________________________________________________________________________ 
Clan A 
 1 1715 14 8 Peptidyl-tRNA hydrolase 2 
 2 7996 31 15 6-Phosphogluconolactonase 
 3 15097 79 74 Peroxiredoxin, alkyl hydroperoxide reductase 
 4 6115 4 19 Carboxymethylenebutenolidase, dienelactone 
     hydrolase 
 5 1216 5 1 α/β-Hydrolase, esterase 
 6 8649 7 14 Carboxylesterase, α/β-hydrolase 3.1.1.1 
 7 23483 27 115 α/β-Hydrolase 
 8 410 5 2 D-Aminoacyl-tRNA deacylase 
 9 6704 17 10 S-Formylglutathione hydrolase 3.1.1.1 
 10 6241 8 14 Carboxylesterase, α/β-hydrolase 
 11 4644 3 2 Esterase, α/β-hydrolase 3.1.1.1 
 12 4994 53 12 Phospholipase A1 
 13 2631 9 5 Monoglyceride lipase, lysophospholipase 3.1.1.5 
 14 1899 5 3 α/β-Hydrolase domain-containing protein,  
     α/β-hydrolase, 2-hydroxymuconic 
     semialdehyde hydrolase 
 15 4038 4 16 Acetylhydrolase, esterase, α/β-hydrolase 3.1.1.1 
 16 13375 21 38 α/β-Hydrolase, lipase 
 17 6084 26 15 2-Hydroxyisoflavanone dehydratase, α/β- 3.1.1.1 
     hydrolase, lipase 
 18 497 5 10 Lipase 
 19 2191 5 14 Acetyl xylan esterase 
 20 3629 14 5 Lysophospholipase, caffeoylshikimate esterase 3.1.1.5 
 21 2593 31 35 Lipase 
 22 1181 9 2 Peroxidase, protein phosphatase methylesterase, 
     α/β-hydrolase 
 23 496 1 2 Lpx1p, hypothetical protein 
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Table 1 continued 
 24 1437 5 6 Platelet-activating factor acetylhydrolase 
 25 730 2 4 Carbohydrate esterase family 15 
 26 2432 9 2 Gastric triacylglycerol lipase precursor, lipase 
     member M 
 27 23684 60 52 Arylacetamide deacetylase (esterase), neutral 3.1.1.1 
     cholesterol ester hydrolase, lipase 
 28 1553 11 4 Patatin-like protein 
 29 1493 10 1 Galactolipase, phospholipase A1, lipase 
 30 3896 2 2 Xylanase, 1,4-β-xylanase 
 31 1648 1 0 Pheophytinase, α/β-hydrolase 
 32 1359 3 14 Protein notum homolog precursor 
 33 10812 32 38 60-kDa Lysophospholipase, cytoplasmic  3.1.1.4, 
     asparaginase I, 1-alkyl-2-acetylglycero- 3.1.1.5 
     phosphocholine esterase 
 34 24560 158 272 Cholinesterase, butyrylcholinesterase, partial 3.1.1.7, 
     acetylcholinesterase 3.1.1.8 
 35 1059 10 0 Lysophospholipase, phospholipase A2 3.1.1.4, 
      3.1.1.5 
 36 688 2 1 Esterase 3.1.1.1 
 37 4538 4 19 Acetylxylan esterase, esterase, glycoside hydrolase 
 38 869 5 0 Diacylglycerol lipase 
Clan B 
 39 5264 4 7 Acyl-CoA thioesterase I, multifunctional acyl- 3.1.1.5, 
     CoA thioesterase I, protease I 3.1.1.1 
 40 1869 2 13 Esterase, lipase, triacylglycerol lipase 3.1.1.1 
 41 1004 6 56 Cutinase 3.1.1.7, 
      3.1.1.74 
 42 1463 14 10 Acetylhydrolase, lipase 
 43 713 2 4 Acetylxylan esterase, cutinase 3.1.1.74 
 44 2262 6 6 Rhamnogalacturonan acetylesterase, GDSL family 
     lipase 
 45 1717 15 43 Methyl esterase 3.1.1.1 
 46 8906 10 15 Polysaccharide deacetylase 
 47 1985 5 4 GDSL family lipase 3.1.1.1 
 48 3765 5 7 2-Pyrone-4,6-dicarboxylate hydrolase,  3.1.1.5 
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Table 1 continued 
     amidohydrolase 
 49 2374 9 18 Lactonizing lipase, α, β-hydrolase 3.1.1.32 
 50 498 7 7 Lecithin-cholesterol acyltransferase 
 51 1537 15 15 Lipase 3.1.1.5, 
      3.1.1.1 
Clan C 
 52 5655 28 9 Carboxylesterase, acyl-protein thioesterase, 3.1.1.5, 
     phospholipase 3.1.1.1 
 53 4262 3 18 Monoacylglycerol lipase, carboxylesterase 
 54 1818 4 2 N-Acylhomoserine lactonase, α/β-hydrolase 
 55 314 1 12 Lipase 
Clan D 
 56 7623 9 9 Regucalcin, gluconolactonase 
 57 1853 2 3 Lactonase, gluconolactonase 
 58 8401 7 5 6-Phosphogluconolactonase 
 59 672 16 7 Serum paraoxonase, arylesterase 
 60 3060 26 16 Retinoid isomerohydrolase, carotenoid oxygenase 
Clan E 
 61 2624 316 279 Phospholipase A2 3.1.1.4 
 62 738 12 1 Phospholipase A2 3.1.1.4 
 63 1693 191 194 Group IID secretory phospholipase A2,  3.1.1.4 
     Group 10, group IIE phospholipase A2 
Clan F 
 64 4051 12 11 Acyl-CoA thioesterase, pectin esterase 
 65 7382 19 12 Pectinesterase 1 precursor 
Clan G 
 66 5348 10 15 Lactonase, lactamase 
 67 1313 3 5 L-Ascorbate 6-phosphate lactonase, β-lactamase 
Not part of a clan 
 68 13 1 0 Phospholipase A2 3.1.1.4 
 69 5037 4 5 Peptidyl-tRNA hydrolase domain protein, 
     peptide chain release factor 1 
 70 438 6 0 Putative peptidyl-tRNA hydrolase 
 71 8877  13 19 D-Tyrosyl-tRNA(Tyr) deacylase 3.1.1.4, 
      3.1.1.32 
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Table 1 continued 
 72 11 11 0 Phospholipase A1, phospholipase A2 
 73 2790 3 1 Chemotaxis protein CheD 
 74 1011 7 7 HRAS-like suppressor, phospholipid-metabolizing 3.1.1.4, 
     enzyme, retinoic acid, receptor responder protein 3.1.1.32 
 75 15 1 0 Hypothetical protein 
 76 1024 2 1 Aldehyde dehydrogenase, lipid A 3-O-deacylase 
 77 728 6 0 Group XIIA secretory phospholipase A2 3.1.1.4 
     precursor, Group XIIB 
 78 11783 16 43 Peptidyl-tRNA hydrolase 
 79 3136 92 4 Peptidyl-tRNA hydrolase ICT1, peptide chain 
     release factor I 
 80 293 3 0 Tip1p, Tir2p, Tir4p 
 81 1234 3 0 Feruloyl esterase, carbohydrate esterase familyl 
 82 1334 1 0 Carboxymethylenebutenolidase, dienelactone 3.1.1.4 
     hydrolase 
 83 34 1 0 Plasmid partitioning protein phospholipase 
 84 4983 4 4 Hypothetical protein, β-lactamase 
 85 3296 2 7 Phospholipase A1  3.1.1.4, 
      3.1.1.32 
 86 2686 8 0 Esterase 
 87 43 1 1 Lipase 
 88 335 1 0 Phospholipase A 
 89 683 1 0 Amidohydrolase 
 90 3091 1 0 Lysophospholipase L2 3.1.1.5 
 91 7012 12 0 GDSL esterase, lipase 
 92 12511 8 4 Chemotaxis-specific methylesterase 
 93 261 4 0 Chlorophyllase 
 94 6298 11 0 GDSL esterase, lipase 
 95 2245 3 2 Dihydroorotase, amidohydrolase, metallo- 
     dependent hydrolase 
 96 84 1 0 Ldh1p 
 97 812 4 1 Rrt2p, iphthamide biosynthesis protein 7 
 98 30281 33 163 β-Lactamase, D-alanyl-D-alanine carboxypeptidase 
     penicillin-binding protein 
 99 284 1 0 Triacylglycerol lipase 
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Table 1 continued 
100  7425 17 0 Monoacylglycerol lipase, α/β-hydrolase 
 101 6175 11 0 α/β-Hydrolase domain-containing, α/β-hydrolase 
 102 2535 1 0 Hydrolase, α/β-hydrolase 
 103 688 2 0 Say1p, lipase, thioesterase, α/β-hydrolase fold 
     protein 
 104 395 10 9 Hemagglutinin-esterase 3.1.1.5 
 105 521 3 9 Holyurethanase, hemolysin E 
 106 514 3 0 Triglyceride lipase-cholesterol esterase, lysosomal 
     acid lipase, cholesteryl esterase 
 107 1828 7 0 Patatin-like phospholipase domain 
 108 212 1 0 Triglyceride lipase ATG15 
 109 8009 3 0 Hydrolase, proteinase 
 110 386 4 1 Senescence-associated carboxylesterase 3.1.1.1 
 111 192 2 0 Yeh2p, Yeh1p 
 112 3312 3 1 Feruloyl esterase, tannase, feruloyl esterase 
 113 2953 2 0 Sialate O-acetylesterase precursor 
 114 332 2 0 Acyloxyacyl hydrolase 
 115 944 13 5 Phospholipase B-like 2 
 116 4270 6 20 Serine esterase hydrolase, peptidase 3.1.1.4, 
      3.1.1.84 
 117 55 1 0 EstP 
 118 799 1 0 Lipase 
 119 2137 75 107 Bifunctional xylanase-xylan deacetylase,  
     1,4-β-xylanase 
 120 439 2 0 Lipase 
 121 2378 30 0 Phospholipase, hypothetical protein 
 122 465 3 0 Cytochrome C1, D-(-)-3-hydroxybutyrate  
     oligomer hydrolase  
 123 2129 12 3 Cytosolic phospholipase A2 3.1.1.4, 
      3.1.1.5 
 124 2358 17 0 Calcium-independent phospholipase A2, patatin 3.1.1.4, 
      3.1.1.5 
 125 1666 5 0 Tgl4p, patatin-like phospholipase 
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Table 1 continued 
 126 8073 11 0 Patatin-like phospholipase domain 3.1.1.5 
     containing 7, lysophospholipase NTE1, cyclic 
     nucleotide-binding protein 
 127 862 13 0 Phospholipase B1 3.1.1.5 
 _______________________________________________________________________________________________ 
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Table 2. Tertiary structural similarity within families. 
_______________________________________________________ 
Family MSA * MSA : RMSD Pavg 
  counta countb 
_______________________________________________________ 
 1 10 9 1.16 96.04 
 2 3 8 1.39 96.17 
 3 6 7 1.17 93.34 
 4 4 2 0.57 98.67 
 5c 0 0 NA NA 
 6 0 0 1.71 91.45 
 7 0 0 1.13 83.59 
 8 11 4 1.48 96.42 
 9 10 15 0.40 94.53 
 10 0 0 1.10 97.01 
 11 2 2 0.08 100.00 
 12 2 7 1.28 91.38 
 13 3 2 0.58 95.90 
 14 6 13 1.13 95.22 
 15 3 0 0.40 98.97 
 16 0 1 1.24 90.63 
 17 3 1 1.40 91.96 
 18 10 8 0.63 99.44 
 19 8 4 0.72 98.57 
 20 5 7 0.58 95.90 
 21 4 1 1.43 93.89 
 22 4 5 2.47 53.07 
 23 3 3 0.47 100.00 
 24 0 1 0.41 99.79 
 25 8 2 0.50 99.72 
 26 3 4 0.87 90.45 
 27 3 1 1.27 89.85 
 28 0 2 0.53 100.00 
 29c 9 8 NA NA 
 30 4 2 1.24 92.53 
 31c 4 2 NA NA 
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Table 2 continued 
 32 1 0 0.62 97.63 
 33 2 9 1.26 54.93 
 34 8 7 0.98 98.73 
 35c 0 0 NA NA 
 36c 3 8 NA NA 
 37 2 1 1.43 65.42 
 38c 6 5 NA NA 
 39 0 0 0.76 98.62 
 40 3 5 0.3 99.91 
 41 11 8 0.42 98.80 
 42 3 1 0.32 99.43 
 43 5 4 0.38 100.00 
 44 3 2 0.52 91.36 
 45 4 12 0.08 100.00 
 46 0 1 0.08 100.00 
 47 2 5 0.61 99.44 
 48 3 4 1.10 97.01 
 49 2 6 1.04 85.35 
 50 1 7 0.53 99.91 
 51 0 0 0.49 98.11 
 52 3 4 1.15 95.08 
 53 3 1 0.92 94.13 
 54 3 3 0.09 100.00 
 55 5 9 0.43 97.88 
 56 4 3 0.57 99.62 
 57 3 4 0.26 98.44 
 58 1 1 0.86 98.63 
 59 10 9 0.68 97.00 
 60 0 0 0.81 97.76 
 61 11 1 1.33 96.85 
 62c 14 6 NA NA 
 63 13 2 0.92 97.32 
 64 4 3 0.51 95.74 
 65 4 2 0.76 96.80 
 66 5 5 0.09 100.00 
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Table 2 continued 
 67 1 0 0.46 90.30 
 68c 10 3 NA    NA 
 69 9 6 1.64 73.69 
 70c 7 9 NA NA 
 71 11 10 0.6 98.67 
 72c 8 6 NA NA 
 73c 4 2 NA NA 
 74 2 11 1.17 84.35 
 75c 3 5 NA NA 
 76c 9 2 NA NA 
 77c 27 14 NA NA 
 78 12 13 1.38 93.98 
 79 6 7 1.25 100.00 
 80c 4 8 NA NA 
 81c 3 2 NA NA 
 82c 5 2 NA NA 
 83c 1 1 NA NA 
 84 2 2 1.13 83.59 
 85 0 1 0.40 94.53 
 86c 4 2 NA NA 
 87c 7 9 NA NA 
 88c 6 3 NA NA 
 89 15 6 NA NA 
 90c 1 1 NA NA 
 91 3 2 NA NA 
 92 7 4 1.38 93.43 
 93c 5 9 NA NA 
 94c 3 3 NA NA 
 95 0 0 1.45 92.18 
 96c 15 11 NA NA 
 97c 10 6 NA NA 
 98 2 1 0.87 90.45 
 99c 6 8 NA NA 
 100c 3 0 NA NA 
 101c 0 1 NA NA 
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Table 2 continued 
 102c 3 10 NA NA 
 103c 6 3 NA NA 
 104 51 32 1.27 92.78 
 105 20 33 0.77 97.79 
 106c 4 5 NA NA 
 107c 0 3 NA NA 
 108c 8 7 NA NA 
 109c 2 4 NA NA 
 110c 4 5 NA NA 
 111c 9 11 NA NA 
 112c 2 7 NA NA 
 113c 11 8 NA NA 
 114c 55 43 NA NA 
 115 0 0 0.76 63.81 
 116 4 0 0.84 95.28 
 117c 7 13 NA NA 
 118c 0 0 NA NA 
 119 1 3 1.32 85.78 
 120c 27 34 NA NA 
 121c 1 4 NA NA 
 122c 1 1 NA NA 
 123 8 8 1.00 99.60 
 124c 4 3 NA NA 
 125c 4 5 NA NA 
 126c 5 3 NA NA 
 127c 4 5 NA NA 
 ______________________________________________________ 
a Total conservation of amino acid residues over multiple sequence 
alignment. 
b Total conservation of chemically similar amino acid residues over 
multiple sequence alignment. 
c Zero or one known tertiary structure in this family. 
  
	   53	  	  
Table 3. Tertiary structural similarity within clans. 
 __________________________________________________________________________________ 
Clan Number of CEH  RMSD Pavg Fold 
 families families (Å) (%) 
 __________________________________________________________________________________ 
A 37 1–38 2.46 25.51 α,β-Hydrolase, 2nd β-strand antiparallel 
B 13 39–52 2.47 54.39 α,β-Hydrolase, all β-strands parallel 
C 4 53–56 2.47 54.39 α,β-Hydrolase, 1st β-strand antiparallel 
D 6 57–62 2.21 70.94 6-Propellor 
E 4 63–66 1.62 52.43 3-α-Helix 
F 2 67–68 1.39 90.54 3-Solenoid 




Figure 1. Tertiary structures from seven clans. They are colored by secondary structures. 
Red indicates α-helices, and yellow indicates β-strands. PDB IDs for each clan above are:  
clan A: 1VA4, clan B: 4PSD, clan C: 3BF8, clan D: 3FGB, clan E: 1C1J, clan F: 1QJV, and 
clan G: 2WYL. 
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Figure 2. Reaction catalyzed by phospholipase A2 (EC 3.1.1.4). Red curve indicates the 
bond to be hydrolyzed. 
 
Figure 3. Reaction catalyzed by acetylcholinesterase (EC 3.1.1.7). Red curve indicates the 
bond to be hydrolyzed. 
 
Figure 4. Reaction catalyzed by carboxylesterase (EC 3.1.1.1). Red curve indicates the bond 
to be hydrolyzed. 
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Figure 5. Cutin structure. Red curve indicates the bond to be hydrolyzed by cutinase (EC 
3.1.1.74). Figure adapted from “Identification and characterization of bacterial cutinase” by 
Chen S et al., 2008, J Biol Chem, 283(38), 25855. 
 
 
Figure 6. Reaction catalyzed by phospholipase A1 (EC 3.1.1.32). Red curve indicates the 
bond to be hydrolyzed. 
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Figure 7. Reaction catalyzed by cocaine esterase (EC 3.1.1.84). Red curve indicates the bond 
to be hydrolyzed. 
 
Figure 8. Reaction catalyzed by triacylglycerol lipase (EC 3.1.1.3). Red curve indicates the 
bond to be hydrolyzed. 
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APPENDIX.  LEARNING  PROTEIN  CRYSTALLIZATION  
CONDITIONS:  ANALYSIS,  OPTIMIZATION,  AND  
APPLICATION  
Introduction  
Protein crystallization is affected by many factors, including chemical parameters like pH, 
precipitant, buffer, additives, and ligands, physical parameters like temperature, pressure, 
time, gravity field, and electric field, and protein parameters like purity, concentration, and 
mutation (Giegé, 2013). It is common for researchers to test hundreds or thousands of com-
binations of conditions to find the appropriate crystallization condition for one protein, and 
this remains a challenging and time-consuming process. Finding the conditions to crystallize 
proteins is a bottleneck for scientists to obtain protein tertiary structures, given the substantial 
gap between the number of protein sequences available from genome projects and the num-
ber of solved protein tertiary structures (Wooh et al., 2003) (Zhu et al., 2006) (Newstead et 
al., 2009) (Zucker et al., 2010) (Parker & Newstead, 2012). 
By studying protein crystallization conditions statistically, we hope to discern the 
relationship among these factors and protein properties. We aim to reduce and optimize the 
crystallization condition sets, in order to decrease the number of trials that researchers need 
to do before crystallizing a protein. This will save both time and resources for researchers, 
especially in the small to medium laboratory scale. 
The greatly increasing number of tertiary structures available on the Protein Data Bank 
(PDB) (Bernstein et al., 1977), (Berman et al., 2000) provides a great resource to extend 
information about protein tertiary structures.  
The detailed objectives of this project were as follows:  
(a) Parse the crystallization condition data on the PDB from plain text format to tabular 
format, to make it easier for further analysis. 
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(b) Analyze the relationships among protein crystallization conditions, protein structures, 
and other protein properties using statistical methods, based on the protein tertiary structure 
information available on the PDB. 
(c) Optimize protein crystallization conditions of particular kind of proteins, to best 
represent the independent condition sets that need to be explored, in order to improve the 
success rate of crystallization. 
Protein  tertiary  structure  and  X-­ray  crystallography  
Protein tertiary structures, or three-dimensional structures, provide important clues about 
enzyme functions, such as their active sites, substrate specificities, and reaction mechanisms. 
Tertiary structures with different precision can give various kinds of biological information. 
For example, the most precise structures, of 1.0 Å resolution, can yield clues about reaction 
mechanism. Structures of 1.5 Å resolution can be used to guide site-directed mutagenesis to 
reveal sequence-structure-function relationships, and to study active sites and binding 
pockets. Structures of 3.5 Å resolution, although low in resolution, can still provide enough 
information to study enzyme functions (Eswar et al., 2006). 
Among the various experimental methods used to determine protein tertiary structures, 
X-ray crystallography is the most widely used, followed by nuclear magnetic resonance 
(NMR) and electron microscopy (EM). X-Ray crystallography contributed 84,406 (89.4%) of 
the 94,415 protein structures available on the PDB, while NMR and EM yielded 9,232 
(9.8%) and 560 (0.6%) structures, respectively (statistics obtained in August 2014). The main 
research objects of this project deal with the crystallization conditions of proteins solved by 
X-ray crystallography, yet comparing protein structures determined by X-ray, NMR, and EM 
will occur as well. 
Protein crystallization is the critical step before a sample is submitted for an X-ray crys-
tallographic study. The protein solution first needs to be purified in high concentration. Then 
the protein solution is brought into a supersaturated state, and hopefully crystals will start to 
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form. The success of this effort depends on many factors, including protein purity and con-
centration, precipitant, buffer type and concentrations, ligands, pH, temperature, pressure, 
time, magnetic field, and electric field in some rare cases. 
Vapor diffusion methods, such as the hanging drop and sitting drop techniques, are the 
most popular methods to obtain protein crystals for X-ray crystallography. Figure 1 shows 
the hanging drop method (Drenth, 2007). The hanging drop on the top of the sealed container 
usually has a lower precipitant concentration than that in the bottom reservoir. Precipitants 
bind with water and compete with the protein for it, increasing the protein concentration in 
the hanging drop as water migrates to the bottom reservoir until its vapor pressure becomes 
equal in the hanging drop and the bottom reservoir. Eventually the protein concentration in 
the drop will become supersaturated. If all the other parameters like pH, buffer, and temper-
ature are appropriate, the protein will start to crystallize. 
 
Figure 1. The hanging drop method for protein crystallization. The grease ensures the 
sealed environment. Figure adapted from Principles of Protein X-ray Crystallography. 
Springer, New York (Drenth, 2007). 
Batch crystallization is the technique that mixes protein and reagents directly to create a 
supersaturated solution, and the mixture is covered by oil to keep it isolated from the envir-
onment. When the system reaches equilibrium, crystals should start to grow. This method is 
suitable for automation and miniaturization, and it is known as the microbatch technique. 
Dialysis is another technique used to change the concentration of precipitants. It is suitable to 
grow large crystals, but it is hard to miniaturize (Rupp, 2010). 
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Previous  studies  on  protein  crystallization  conditions  
Giegé (2013) summarized the parameters of crystallization conditions extensively in his 
review about protein crystallization history to the present day. Precipitants, buffers, pH, tem-
perature, ligands, additives, and detergents for membrane proteins are the main parameters 
for protein crystallization. Pressure, temperature, time, gravity field, and electric field also 
affect crystallization. Last but not least, the protein itself can be regarded as the most signif-
icant parameter. This includes the purity, concentration, mutation, truncation, and deletion of 
the protein (Dale et al., 2003). 
Precipitants are compounds that bind water and compete with proteins for it, so that the 
proteins have more difficulty in accessing water, and the protein concentration is considered 
to be higher than those in the same amount of water without precipitant. Polyethylene glycol 
(PEG) (Figure 2) is a widely used polymer precipitant. Salts, organic molecules, and ionic 
liquids, such as ammonium sulfate and 2-methyl-2,4-pentanediol (MPD), are also used as 
precipitants. Buffer is employed to maintain a certain pH of the protein solution, and to 
provide a specific local charge distribution of the protein. The latter contributes significantly 
in the intermolecular interaction leading to crystal formation (Rupp, 2010). Additives include 
everything else that promotes crystallization, and they are added when there is protein 
aggregation during crystallization, small-sized crystals, or weak diffraction in X-ray crystal-
lography. 
Figure 2. Chemical structure of PEG. This polymer has molecular weights from 300 
g/mol to 10,000,000 g/mol. PEG used as precipitant usually has mean molecular weights 
from 300 to 10,000 g/mol. For example, PEG 400 refers to PEG that has a 400 g/mol mean 
molecular weight.  
 
	   61	  	  
Continual efforts have been devoted to protein crystallization since the first discovery of 
hemoglobin protein crystals in blood in 1840 by Hunefeld (Giegé, 2013). Several studies 
have emerged since the 1990s to try to rationalize protein crystallization conditions, although 
these various parameters mentioned above make it impossible to exhaust all the combinations 
of crystallization conditions (Luft et al., 2011). Jancarik and Kim (1991) developed a screen-
ing method, sparse matrix sampling, based on published crystallization conditions. This 
sampling method has three major variables: pH and buffer materials, precipitants, and 
additives. Statistically, it uses the Carter and Carter (1979) incomplete factorial method to 
decrease the number of screening conditions. Fifty conditions were proposed to effectively 
cover the wide range of pH, precipitants, and additives. Fifteen previously crystallized 
proteins are used as test data. Crystals were obtained successfully from all of the proteins by 
using at least one of these 50 conditions. The Jancarik and Kim screening method is widely 
used and remains popular, as it assumes no a priori knowledge for the protein to be crystal-
lized, and it can be applied for proteins with limited information on their properties. Yet this 
is occasionally not as effective as it is in other circumstances: when protein properties are 
known, it does not incorporate the information into the crystallization conditions. 
Some popular crystallization condition kits were also commercialized and available from 
several companies, such as Qiagen, Molecular Dimensions, and Hampton Research. The 
Joint Center for Structural Genomics (JCSG) tested 480 commercially available conditions 
for the Thermotoga maritima proteome, found the redundancy in these commercial 
conditions, and minimized them to the 67 most effective ones (Page et al., 2003). A 
systematic study of pH, anion and cation-testing (PACT) screening conditions with PEG 
were also developed and tested (Newman et al., 2005). Their research results were converted 
into the JCSG+ and PACT commercial kits. 
The correlation between protein isoelectric point (pI) and pH of the protein crystallization 
solution was investigated (Kantardjieff & Rupp, 2004). A total of 9,596 unique protein crys-
tals from the PDB were studied, and a significant relationship (R2 = 0.62), although not a dir-
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ect correlation, was found between pI and the difference between pH and pI (pH – pI). The pI 
values are calculated using the pKa values of Bjellqvist et al. (1993). Based on this relation-
ship, a prototype pH range calculator (CrysPred) was developed. This server-based tool aims 
to optimize the efficiency of initial crystallization screening conditions, with a predicted 
saving of material of 30 to 50%. 
Membrane proteins, of rising interest due to their relevance with human diseases and 
medicines, are studied individually for their crystallization conditions (Newstead et al., 2009), 
(Parker and Newstead, 2012). Compared to soluble proteins, membrane proteins need deter-
gents to isolate and solubilize them, which adds an additional parameter to the crystallization 
process. Membrane proteins were classified by their functions into eight groups, such as 
channels, transporters, and receptors. The variables, including detergents, precipitants, 
buffers, pH range, and salts, are visualized against the number of successful crystallizations. 
Their analysis led to the commercial screening kits MemGold (2009) and MemGold2 (2012), 
designed for membrane proteins. 
The Biological Macromolecule Crystallization Database (BMCD) (Gilliland et al., 1996),	  
(Tung & Gallagher, 2009) is a manually curated database that provides detailed information 
about crystallization since 1988. The crystallization details, collected from the literature, are 
listed as macromolecular concentration, pH, temperature, and growth time, while crystallizat-
ion solutions are recorded as reagent type, concentration, and dimension. Several crystalliz-
ation studies have been based on the data obtained from the BMCD. Cluster analysis of 
crystallization parameters, including pH, temperature, molecular weight, macromolecular 
concentration, precipitant type, and crystallization methods, has been conducted based on 
BMCD data (Samudzi et al., 1992), (Farr et al., 1998), and XtalBase (Meining, 2006), and is 
a web-based tool to generate new condition sets for crystallization experiments. 
On the other hand, due to the exponential growth in available tertiary structures, infor-
mation on crystallization conditions leading to these structures expands rapidly. The PDB has 
become the comprehensive resource when researchers need information about crystallization 
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conditions, as the BMCD has been updated less frequently as of late. However, all the 
crystallization conditions in the PDB are recorded in plain text but in varying formats. For 
instance, ammonium sulfate has more than 30 spelling alternatives (Peat et al., 2005). The 
variation in chemical names and dimensions has hampered the further data analysis of 
crystallization conditions. Therefore, Newman and colleagues (2014) constructed a standard 
dictionary to map chemical names to their aliases, together with their common classes and 
dimensions, and proposed a rule for standard nomenclature used in macromolecular 
crystallization. 
Glycoproteins  
Glycoproteins are proteins that have sugars, or glycans, covalently attached to protein 
side chains. About half of all human proteins may be glycosylated (Apweiler et al., 1999). 
There are two common types of glycosylation: N-glycosylation and O-glycosylation. N-
glycosylation often occurs where the protein has the specific sequence Asn–X–Ser/Thr/Cys–
X, where X is any amino acid except proline. O-glycosylation often exists in an area of the 
protein with large numbers of serine, threonine, and proline residues (Nettleship, 2012). 
In terms of structural biology, various glycans that increase the heterogeneity of the 
protein surface can affect the protein structure. Furthermore, the overall glycan mass can be 
from 1% to 80% of the glycoprotein total mass (Varki et al., 2009). The variation of glycan 
type and number may in some cases hamper protein crystallization. On the other hand, 
glycan presence can sometimes benefit crystallization when it allows intermolecular contact. 
Statistical  methods  of  data  mining  
The PDB stores plenty of information in each PDB file, such as the protein name, protein 
function by EC number (Webb, 1992), structure classification by CATH (Sillitoe et al., 2012) 
and SCOP database (Murzin et al., 1995), as well as methods and conditions to obtain crys-
tals and the three-dimensional coordinates of each atom. With PDB entries growing exponen-
tially, we have more structural information available than ever before. Such large databases 
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usually contain hidden knowledge, and they can be further investigated by statistical 
methods, such as by so-called data mining. Data mining involves using knowledge from 
statistics, database management, computer science, and machine learning (Fayyad et al., 
1996). 
Supervised learning and unsupervised learning are two common algorithm types in 
machine learning methods. Supervised learning uses data with predefined output as a training 
dataset, to generate functions to map input data with known output data. Then it uses gener-
ated functions to predict the output value for a new input dataset. Widely used supervised 
learning algorithms are support vector machine (SVM) (Cortes & Vapnik, 1995), k-nearest 
neighbor (KNN) (Altman, 1992), and neural network (NN) (Hagan et al., 1996). 
Unsupervised learning tries to find hidden patterns in previously undefined data. Unlike 
supervised learning, unsupervised learning does not have predefined output data, so it uses 
computation to find the groups of similar input data on its own. This kind of grouping is 
called clustering, where hierarchical clustering (Sibson, 1973)  and centroid-based clustering 
(Lloyd, 1982) are two common clustering methods. 
Previous  studies  on  biological  problems  using  data  mining  
Researchers have successfully applied supervised and unsupervised learning techniques 
to study various biological problems. Protein structure classification (Krishnaraj and Reddy, 
2010) and transmembrane protein topology prediction (Jones, 2007) are two data mining 
examples related to protein structures. These two examples will be summarized, focusing on 
the way to pre-process the dataset, the methods used to perform data mining, and the evaluat-
ion of the results inferred from the biological data, in the following paragraphs. 
Protein structure classification sorts protein tertiary structures into corresponding protein 
folds. This can be approached using various supervised learning methods, such as SVM, 
KNN, NN, and boosting. The accuracy and efficiency of these methods are compared in the 
work of Krishnaraj and Reddy (2010). The dataset is from the SCOP database (Murzin et al., 
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1995): a training set of 311 proteins with no more than 35% sequence identity from 27 repre-
sentative SCOP fold are selected, and the test data are 383 proteins from the same 27 folds 
with no more than 40% sequence identity, excluding the training set. The parameters, or 
features, of the datasets are: amino acid composition, predicted secondary structure, hydro-
phobicity, polarity, normalized van der Waals volume, and polarizability. For each protein, 
these six parameters are extracted. Then SVM, KNN, NN, and boosting methods are applied 
to classify the protein structures. The measurement to evaluate the classification is the 
standard Q percentage accuracy. Qi equals the number of correct predicted proteins in fold i 
divided by total number of test proteins in number n, and Q equals the weighted average of 
individual fold accuracy Qi. Using the evaluation criteria, the boosting method performs 
better than other supervised methods to solve the protein structure classification problem. 
Predicting transmembrane protein topology is another problem to which the machine 
learning technique has been applied. Jones (2007) used the neural network methods in 
MEMSAT3 to predict the secondary structure of transmembrane proteins, and this method 
has better accuracy (80%) than other methods that have 62–72% accuracy. MEMSAT3 
combines the existing MEMSAT2 methods with the sequence conservation information 
using neural network methods. As for the dataset, it uses 184 proteins where their topology is 
known experimentally. Each of the 184 proteins is used as a separate training set to allow the 
cross-validation. To evaluate the results, three criteria are applied: The number of transmem-
brane helices, the topology, and the location of the transmembrane regions were all correctly 
predicted. The results were plotted to compare MEMSAT3 and other four methods, including 
MEMSAT2. The data set was also divided into subsets by organism and single- or multiple-
spanning proteins to show their accuracy in subsets using different methods. The evaluation 
is also illustrated in plots such as false-positive rate on identifying globular proteins and 
false-negative rate on transmembrane proteins. 
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Methods  
Crystallization  data  acquisition  
Protein crystallization data and information about their corresponding protein properties 
were obtained from the PDB. Protein structures determined by X-ray crystallography were of 
research interest. If more than one PDB entry with exactly the same sequence exists, only 
one of the entries was included in the data set. Customized reports of crystallization details 
and various protein properties were downloaded from the PDB. The protein properties range 
from structure resolution and source organism, to structure type from the CATH protein 
structure classification database (Sillitoe et al., 2012). Table 1 contains a full list of the 
protein properties in our data set. 
Table 1. Protein attributes obtained from the PDB. 
The crystallization details to experimentally obtain the protein structure, such as precip-
itant and buffer type and their concentrations, are recorded in plain text in the crystal growth 
procedure in the PDB. Not every PDB entry has detailed crystal growth procedures, thus 
entries of fewer than seven characters in this field were discarded, because they had no or a 
limited amount of information, like the pH or temperature, while these values can be found 
separately elsewhere in the record. 
Data  preprocessing  
In order to recognize and separate different reagents into precipitant, buffer, salt, additive, 
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and detergent categories and their concentrations, the raw PDB data were processed by a 
series of in-house Python scripts, described as follows. A comprehensive list (plist) of precip-
itants, buffers, salts, additives, and other reagents was created to guide the text separation. It 
was summarized based on the common types of known reagents, and every entry in the list 
became the keyword in the following search. Based on the standard names and their alias 
summarized by Newman and her colleagues (2014), a name list was created to map various 
names from the PDB into standard chemical names of our data set. The keywords of the plist 
are formatted into standard name from the name list. Next, the text of crystal growth proced-
ure downloaded from the PDB was first divided into pieces by commas, and then each piece 
was searched by the keywords and their aliases in the name list. If any keyword or alias was 
found, the text before the name was checked for the reagent concentration and its dimension, 
and its standard name instead of the alias was recorded. In this way, the results of the crys-
tallization conditions were formatted and written into a new CSV (comma-separated values) 
file. If multiple chemicals exist in one reagent class, for example, if two chemicals are used 
as additives, they are written in one entry into the result file, but will be separated later in the 
data analysis. Finally, the formatted data were combined with protein properties from the 
PDB, and they were used for further analysis using Python and the data mining software 
WEKA (Witten et al., 2011). 
Preliminary  results  
Crystallization  condition  data  format  
The plain text of the materials added to further the crystallization of PDB entries were 
classified into precipitants, buffers, salts, additives, and detergents, if available. Their con-
centrations and dimensions are also recorded, if provided, into a CSV file, with some excep-
tions to be finished in future work. This unified format helps the further analysis of data 
mining of the crystallization conditions. 
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CATH  groups  and  crystallization  
The CATH database classifies protein structures (Sillitoe et al., 2012) into four hierar-
chies: class, architecture, topology, and homologous superfamilies. Class is the top hierarchy, 
divided based on secondary structure. Class 1 holds mainly α-helices, class 2 has mainly β-
strands, class 3 contains α and β structures, and class 4 includes a few irregular secondary 
structures. Within each class, their architectures are then classified based on the arrangement 
similarity of secondary structure on three-dimensional space. Five, twenty, fourteen, and one 
architectural groups exist within the four classes, respectively. In the topology levels, the 
connectivity between secondary structures is considered. Finally, homologous superfamilies 
group proteins according to similar structures, sequences, or functions. 
The number of PDB protein structures determined by X-ray and NMR is listed in the 
forty second-level CATH groups. The total number of structures with CATH classification 
found by X-ray and NMR are about 16,400 and 2,800, respectively. The three-layer (α-β-α) 
sandwich (CATH 3.40) is the most common structure determined by X-ray, followed by the 
orthogonal bundle (CATH 1.10) and the two-layer sandwich (CATH 3.30). The latter two 
CATH groups are also the most popular groups determined by NMR. Within the top ten 
popular CATH groups for each method, X-ray and NMR share eight of them. On the other 
hand, tertiary structures of α-β barrel (CATH 3.20) and α-β complex (CATH 3.90) proteins 
are mainly determined by X-ray crystallography, whereas structures of proteins of irregular  
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Figure 3. The number of PDB protein structures in second-level CATH groups 
determined by X-ray (in blue) and to NMR (in red). 
The molecular weights of PDB structures by CATH groups are shown in Figure 4. The 
average molecular weight of those determined by X-ray covers a wide range, from 20 kDa to 
160 kDa. Samples subjected to X-ray have higher molecular weights than those subjected to  
Figure 4. The average structure molecular weight (kDa) in second-level CATH groups 
determined by X-ray (in blue) and NMR (in red). 
NMR in most cases, as the latter is known to be limited to solving protein structures less than 
50 kDa. The only exception in this case is CATH 3.60, where two proteins, 2KU1 and 2KU2, 
were solved by TROSY-NMR (Religa et al., 2010) and overcame this limit. Since these two 
proteins are the only ones solved by NMR in CATH 3.60, an exceptional average molecular 
weight results (Figure 4). Other groups determined by NMR have average molecular weights 
between 10 kDa and 20 kDa. 
The resolutions of various CATH groups are shown below in Figure 5. Generally, the 
median resolutions (red dashes) of second-level CATH groups are around 2 Å. The groups of 
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α-solenoids (CATH 1.40) and three-layer sandwiches (CATH 2.102) have resolutions around 
1.5 Å. CATH groups with more outliers (blue crosses) such as CATH 1.10, CATH 2.40, and 
CATH 3.40, overlap with the groups with higher number of X-ray crystal structures in Figure 









Figure 5. The boxplot of resolution (Å) in second-level CATH groups.   
Prediction  of  CATH  groups  by  crystallization  conditions  
This is based on the hypothesis that crystallization conditions differ in crystallizing 
various tertiary structures, classified by CATH groups. Thus, computation can classify 
successfully crystallized proteins into CATH groups by their crystallization conditions and 
protein properties such as molecular weight. If tertiary structures in different CATH groups 
can be correlated with various crystallization conditions, we can infer that proteins in 
different CATH groups prefer diverse crystallization conditions. 
All proteins with available CATH group classification from the PDB, totaling 15,428 
PDB entries, were downloaded. The crystallization conditions were parsed into precipitant, 
buffer, temperature, and pH values using Python scripts. The information was imported to the 
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learning was performed, as we use the forty second-level and four first-level CATH groups, 
as the labels. Several methods were implemented and evaluated by tenfold cross-validation. 
This validation method divided the dataset into ten subsets, with nine sets used to train the 
model, and the tenth subset used to test the correctness of the model, for ten iterations. 
Since many machine learning algorithms exist, algorithms from each kind that are suit-
able for the datasets are implemented and tested. Decision trees are constructed by dividing 
an attribute into branches for each possible value, and dividing each branches recursively, 
until all instances in the nodes have the same classification. Rule methods examine each class 
in turn and try to cover all the instances in it, and this is reversed to the top-down methods of 
decision tree. Function classifiers are those that can be written naturally in mathematical 
equations. Bayesian classifiers are those use Bayes theorem explicitly to solve problems. 
Ensemble methods use multiple models to train the data independently and combine them in 
some way to improve the prediction (Witten et al., 2011). 
Table 2. The methods used to predict CATH groups and cross-validation results. Five 












Decision tree - J48 26.5 73.5 0.0084 0.521 
Bayes - Naïve Bayes 25.0 75.0 0.0014 0.509 
Lazy - IBK (kNN) 18.0 82.0 0.0279 0.530 
Rule - OneR 26.6 73.4 0.0133 0.506 
As shown in Table 2, the crystallization conditions successfully predicted second-level 
CATH groups < 30% of the time by each of the four different methods. The kappa statistics 
correct the overall success rate by deducting the success rate occurring by chance, as shown 
below (Witten et al., 2011): 
Kappa = (observed	  accuracy	   − 	  expected	  accuracy)/(1	   − 	  expected	  accuracy) 
The observed accuracy is the correctly predicted instances for all classes divided by the 
total number of instances. The expected accuracy is the accuracy that any random predictor 
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can occur by chance. Kappa statistics over 0.75 are considered excellent, 0.4 to 0.75 as fair to 
good, and lower than 0.4 as slight (Fleiss, 1981). The ROC curves, or receiver operating 
characteristic curves, are plotted by the true positive rate against the false positive rate, as 
shown below. The ROC area refers to the area under ROC curves, where one is a perfect 
classification, and 0.5 means a random guess. 
True positive rate =	  TP/(TP	   + 	  FN).   False positive rate =	  FP/(FP	   + 	  TN) 
where TP is true positive, FN is false negative, FP is false positive, and TN is true negative. 
Table 3. The methods used to predict CATH groups and the cross-validation results. Six 
attributes include precipitant, buffer, temperature, pH, structure molecular weight, and first-









statistic ROC area 
Ensemble method - 
Random Forest 56.2 43.8 0.1094 0.596 
Decision tree - J48 57.3 42.7 0.0284 0.561 
Lazy - IBK (KNN) 46.3 53.7 0.0771 0.542 
Bayes - Naïve Bayes 55.7 44.3 0.0018 0.536 
Bayes - Bayes NET 57.2 42.8 0.0541 0.585 
Table 3 shows the prediction of first-level CATH groups by crystallization conditions 
using various methods. Using five different methods, the average correctly classified instance 
rate is around 54.5%, with low kappa statistics and ROC areas. The increase in the number of 
correctly classified instances from second-level to first-level CATH groups is mainly because 
the decrease of group numbers from forty to four. This indicates that CATH groups, of either 
first-level or second-level, are difficult to predict successfully based on crystallization condit-
ions. This also implies that the overall shape of the protein structure and the arrangement of 
secondary structure might not be a main factor that affects crystallization conditions. 
Resolution  
Structure resolution is a measurement indicating the quality of data obtained from X-ray 
crystallography. The higher the resolution is, indicated by low Å values, the better the crystal 
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data will be. When the crystals are highly ordered in an identical way, the X-ray diffraction 
pattern of all the proteins in the crystal will be the same, yielding a high-resolution structure 
around 1 Å with the electron density map showing each atom clearly. When the proteins are 
in slightly different locations in crystals because of local flexibility or movement, the diffrac-
tion pattern will not be so detailed, so that only the contours of protein chains will be detec-
ted and the atomic structure will be inferred.  
The protein resolutions of structures determined by X-ray crystallography are shown in 
Figure 4. Structures near a resolution of 2.0 Å have the largest population, while the resolut-
ion range is mainly from 0.75 Å to 3.5 Å. Structures of resolution less than 1.5 Å usually are 
clear enough to see the proteins at atomic level, and the structures have almost no error from 
the electron density maps. Such structures are around 15% of the PDB. Proteins with resolut-
ion greater than 3.0 Å, which are about 5% of the PDB, can have correctly determined secon-
dary structure elements, although their side-chain structure may have many errors. Structures 
between these two extremes are the main part of the PDB, with their structures near 2.0 Å 
resolution being most commonly found. 
Figure 6. Resolution distribution and the counts of protein crystals in the PDB. 
pH  values  
    The pH value during crystallization is a constantly reported variable. The effect of pH on 
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histogram of pH values in the PDB protein crystals, which ranges from around pH 3 to pH 
11. Interestingly, the most prevalent pH ranges are 6–6.5 and 7.5–8, where the range in 
between these two bins (around 7) is less populated. Diagrams of PH values with other 




















Figure 8. Scatter plots of pH values and (a) structure molecular weight (Da) (b) ligand 
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Temperature  
Temperature during crystallization is another constantly reported variable. Figure 9 is the 
histogram of temperature of protein crystals in the PDB from 250K to 340K. This excludes 
temperature outliers that are lower than 100 K (less than 1% of the total counts). These 
outliers may be caused by manual confusion of Kelvin with degrees Celsius and degrees 
Fahrenheit. Temperatures around 275 K, 290 K, and 300 K are most popular, mainly because 
experiments are conducted in these cold-room or room temperature. Figure 10 contains the 
diagrams of temperature versus other variables.  
 
Figure 9.  Temperature (K) distribution and the counts of protein crystals in the PDB. 
  




















Figure 10. Scatter plots of temperature (K) and (a) structure molecular weight (Da); (b)   
ligand molecular weight (Da); (c) resolution (Å); (d) percent solvent content (%).  
Percent  solvent  content  
The solvent content is the crystal volume occupied by solvent. A general trend was found 
that crystals with less solvent content generally have higher-resolution structures, or smaller 

















Figure 11. The relationship of percent solvent content and resolution. The linear 
regression yields y = (0.0219 ± 0.0002) x + (0.931 ± 0.012), where the ranges are the 
standard errors, y is the resolution (Å), and x is the % solvent content. The 95% confidence 
level intervals of the slope and intercept are 0.0214 to 0.0224 and 0.906 to 0.955, 
respectively. 
Besides some outliers of less than 10% solvent content that have lower resolution than 
expected and a few outliers with exceptionally low resolution (>5 Å), the general trend is that 
the higher the percent solvent content, the lower the resolution. 
Crystallization  of  glycoproteins  
Glycoproteins are of interest because their glycans can be on the protein surface, which 
may affect crystallization. The numbers of crystal conditions, including precipitants, buffers, 
salts, and additives, necessary to crystallize glycoprotein crystal structures in the PDB is 
compared to those necessary to crystallize other protein crystal structures in the PDB in 
Figure 12. The total number may indicate the difficulty of protein crystallization, as more 
reagents do not need to be added if fewer reagents already give crystals of high quality. As 
shown in Figure 6, glycoproteins need about the same number of conditions as other proteins. 
Three conditions are most commonly required for successful crystallization, followed by two 
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and four conditions. This probably indicates that the difficulty of crystallizing glycoproteins 
is the same as that of crystallizing proteins in general. 
Figure 12. The number of crystallization conditions and successful PDB counts of all 
other proteins (left) and glycoproteins (right) determined by X-ray crystallography. 
The commonly used precipitants are summarized by the order of their popularity in Table 
4 of glycoproteins and other proteins. In general, the top ten precipitant types are similar, 
where pentaerythritol propoxylate is used in glycoproteins but not in the other proteins. PEG, 
the most popular precipitant, appears in 80.6% of glycoprotein crystallization cocktails, 
whereas the number is 74.7% in other proteins. 
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Table 4. The most popular precipitants used in crystalizing glycoprotein (left) and other 
protein (right), with their percentage of the total precipitant counts.  
Glycoprotein Other proteins 
Precipitant type % Precipitant type          % 
PEG 80.6 PEG 74.7 
Ammonium sulfate 11.4 Ammonium sulfate 13.5 
MPD 1.9 MPD 3.4 
Jeffamine 0.8 Sodium chloride 3.4 
Sodium chloride 2.8 Lithium sulfate 1.5 
Lithium sulfate              1.0 Sodium phosphate 1.2 
Propanol 0.4 Propanol  0.9 
Sodium phosphate             0.4 Jeffamine 0.4 
Pentaerythritol 
propoxylate  0.2 Tacsimate 0.3 







Figure 13. The different types of PEG used for crystallization, indicated by their molecular 
weights (g/mol) for all other proteins (left) and for glycoproteins (right).   
As the most-used precipitant, PEGs of various molecular weights are summarized in 
Figure 13 of glycoproteins and for other proteins. The frequencies of PEG types, ranging 
from 200 to 35,000 g/mol, used in crystallization conditions are almost the same for the two 
groups. From the diagram, PEG 3000 to PEG 4000 are most prevalent, followed by PEG 400 
and PEG 8000. 









PEG type (g/mol) PEG type (g/mol) 
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